{"items": "88", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term", "url": "https://www.zacks.com/stock/news/2386694/buy-5-genomics-synthetic-biology-stocks-likely-to-soar-in-short-term", "time_published": "20241223T124900", "authors": ["Nalak Das"], "summary": "These five geonomics and synthetic biology stocks are likely to soar in the short-term. They Are: CRSP, IMCR, GLUE, RIGL, CSTL.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.149735, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMCR", "relevance_score": "0.246582", "ticker_sentiment_score": "0.169061", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RIGL", "relevance_score": "0.124809", "ticker_sentiment_score": "0.02377", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRSP", "relevance_score": "0.124809", "ticker_sentiment_score": "0.044541", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.246582", "ticker_sentiment_score": "0.055241", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.206509", "ticker_sentiment_score": "0.07964", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors", "url": "https://www.globenewswire.com/news-release/2024/12/13/2996712/0/en/Monte-Rosa-Therapeutics-Appoints-Dr-Eric-A-Hughes-to-Board-of-Directors.html", "time_published": "20241213T120000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "BOSTON, Dec. 13, 2024 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( Nasdaq: GLUE ) , a clinical-stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the appointment of Eric A. Hughes, M.D, Ph.D., to its Board of Directors.", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.055595, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.247838", "ticker_sentiment_score": "-0.044661", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.062926", "ticker_sentiment_score": "-0.033021", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.062926", "ticker_sentiment_score": "-0.033021", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/24/12/g42481101/monte-rosa-therapeutics-appoints-dr-eric-a-hughes-to-board-of-directors", "time_published": "20241213T120000", "authors": ["Globe Newswire"], "summary": "BOSTON, Dec. 13, 2024 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. GLUE, a clinical-stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the appointment of Eric A. Hughes, M.D, Ph.D., to its Board of Directors.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.081964, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.230782", "ticker_sentiment_score": "-0.040284", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.058472", "ticker_sentiment_score": "-0.032999", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.058472", "ticker_sentiment_score": "-0.032999", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces Closing of Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders", "url": "https://www.globenewswire.com/news-release/2024/12/11/2995244/0/en/Monte-Rosa-Therapeutics-Announces-Closing-of-Global-License-Agreement-with-Novartis-to-Advance-T-and-B-Cell-modulating-VAV1-directed-Molecular-Glue-Degraders.html", "time_published": "20241211T120000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "Monte Rosa Therapeutics Announces Closing of Global License Agreement with ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.009623, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.077218", "ticker_sentiment_score": "-0.073016", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer Symposium on the Potential of its CDK2-directed Molecular Glue Degraders to Treat HR-positive/HER2-negative Breast Cancer", "url": "https://www.globenewswire.com/news-release/2024/12/11/2995243/0/en/Monte-Rosa-Therapeutics-Presents-Preclinical-Data-at-the-2024-San-Antonio-Breast-Cancer-Symposium-on-the-Potential-of-its-CDK2-directed-Molecular-Glue-Degraders-to-Treat-HR-positiv.html", "time_published": "20241211T120000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer Symposium on the Potential of its CDK2-directed Molecular Glue ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.233554, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.136113", "ticker_sentiment_score": "-0.134279", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Provides Development Progress Update for Ongoing MRT-2359 Phase 1/2 Study in Patients with MYC-driven Solid Tumors", "url": "https://www.globenewswire.com/news-release/2024/12/05/2992220/0/en/Monte-Rosa-Therapeutics-Provides-Development-Progress-Update-for-Ongoing-MRT-2359-Phase-1-2-Study-in-Patients-with-MYC-driven-Solid-Tumors.html", "time_published": "20241205T120000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "Results from dose escalation arms of Phase 1/2 study of MRT-2359 demonstrated a favorable safety profile and targeted levels of GSPT1 degradation using a 21 days on, 7 days off drug dosing schedule in heavily pretreated solid tumor patients", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.038746, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.094576", "ticker_sentiment_score": "-0.016255", "ticker_sentiment_label": "Neutral"}]}, {"title": "Wall Street Analysts See a 64.09% Upside in Monte Rosa Therapeutics  ( GLUE ) : Can the Stock Really Move This High?", "url": "https://www.zacks.com/stock/news/2377939/wall-street-analysts-see-a-6409-upside-in-monte-rosa-therapeutics-glue-can-the-stock-really-move-this-high", "time_published": "20241202T224436", "authors": ["Zacks Equity Research"], "summary": "The mean of analysts' price targets for Monte Rosa Therapeutics (GLUE) points to a 64.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default190.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.2519, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.285526", "ticker_sentiment_score": "0.367514", "ticker_sentiment_label": "Bullish"}]}, {"title": "Monte Rosa Therapeutics to Participate in the Piper Sandler Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2024/11/26/2987333/0/en/Monte-Rosa-Therapeutics-to-Participate-in-the-Piper-Sandler-Healthcare-Conference.html", "time_published": "20241126T120000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "BOSTON, Nov. 26, 2024 ( GLOBE NEWSWIRE ) -- ( Nasdaq: GLUE ) , a clinical-stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced that Markus Warmuth, M.D., Chief Executive Officer, will participate in a fireside chat at the 36th Annual ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.149749, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.263942", "ticker_sentiment_score": "-0.17475", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Wall Street Analysts Think Monte Rosa Therapeutics  ( GLUE )  Could Surge 100.47%: Read This Before Placing a Bet", "url": "https://www.zacks.com/stock/news/2371088/wall-street-analysts-think-monte-rosa-therapeutics-glue-could-surge-10047-read-this-before-placing-a-bet", "time_published": "20241115T145510", "authors": ["Zacks Equity Research"], "summary": "The mean of analysts' price targets for Monte Rosa Therapeutics (GLUE) points to a 100.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default188.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.243206, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.284861", "ticker_sentiment_score": "0.366893", "ticker_sentiment_label": "Bullish"}]}, {"title": "Monte Rosa Therapeutics  ( GLUE )  Reports Q3 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2366101/monte-rosa-therapeutics-glue-reports-q3-loss-tops-revenue-estimates", "time_published": "20241107T133506", "authors": ["Zacks Equity Research"], "summary": "Monte Rosa Therapeutics (GLUE) delivered earnings and revenue surprises of 35.56% and 103.13%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default190.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999336"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.156258, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.410059", "ticker_sentiment_score": "0.221552", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SCPH", "relevance_score": "0.212425", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Are You Looking for a Top Momentum Pick? Why Monte Rosa Therapeutics  ( GLUE )  is a Great Choice", "url": "https://www.zacks.com/stock/news/2365457/are-you-looking-for-a-top-momentum-pick-why-monte-rosa-therapeutics-glue-is-a-great-choice", "time_published": "20241106T170013", "authors": ["Zacks Equity Research"], "summary": "Does Monte Rosa Therapeutics (GLUE) have what it takes to be a top stock pick for momentum investors? Let's find out.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default14.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}], "overall_sentiment_score": 0.313768, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.587597", "ticker_sentiment_score": "0.396767", "ticker_sentiment_label": "Bullish"}]}, {"title": "Wall Street Analysts Believe Monte Rosa Therapeutics  ( GLUE )  Could Rally 67.24%: Here's is How to Trade", "url": "https://www.zacks.com/stock/news/2360696/wall-street-analysts-believe-monte-rosa-therapeutics-glue-could-rally-6724-heres-is-how-to-trade", "time_published": "20241030T135504", "authors": ["Zacks Equity Research"], "summary": "The average of price targets set by Wall Street analysts indicates a potential upside of 67.2% in Monte Rosa Therapeutics (GLUE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default80.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.227276, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.2842", "ticker_sentiment_score": "0.366274", "ticker_sentiment_label": "Bullish"}]}, {"title": "Novartis Ag  ( NVS )  Q3 2024 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2024/10/29/novartis-ag-nvs-q3-2024-earnings-call-transcript/", "time_published": "20241029T170011", "authors": ["Motley Fool Transcribing"], "summary": "NVS earnings call for the period ending September 30, 2024.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.839681"}, {"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.9545"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.315883, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BCS", "relevance_score": "0.004131", "ticker_sentiment_score": "0.202072", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ASOMF", "relevance_score": "0.004131", "ticker_sentiment_score": "0.019583", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.004131", "ticker_sentiment_score": "0.2142", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GLUE", "relevance_score": "0.004131", "ticker_sentiment_score": "0.120363", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.004131", "ticker_sentiment_score": "0.202072", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FOREX:CHF", "relevance_score": "0.008261", "ticker_sentiment_score": "0.043454", "ticker_sentiment_label": "Neutral"}]}, {"title": "PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday - PROCEPT BioRobotics  ( NASDAQ:PRCT ) ", "url": "https://www.benzinga.com/news/earnings/24/10/41576730/procept-biorobotics-posts-strong-q3-earnings-joins-monte-rosa-therapeutics-eyepoint-pharmaceuticals", "time_published": "20241028T141458", "authors": ["Avi Kapoor"], "summary": "U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Monday. Shares of PROCEPT BioRobotics Corporation PRCT rose sharply during Monday's session after the company reported better-than-expected third-quarter financial results and raised its FY24 revenue guidance.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/28/Nvidia--Palantir--Clover-Health--Joby-Av.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.366193, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "MSTR", "relevance_score": "0.198221", "ticker_sentiment_score": "0.313791", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NWL", "relevance_score": "0.293506", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.198221", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCORF", "relevance_score": "0.09989", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DJT", "relevance_score": "0.198221", "ticker_sentiment_score": "0.186543", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SERV", "relevance_score": "0.293506", "ticker_sentiment_score": "0.196651", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GLUE", "relevance_score": "0.198221", "ticker_sentiment_score": "0.205525", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRCT", "relevance_score": "0.293506", "ticker_sentiment_score": "0.452204", "ticker_sentiment_label": "Bullish"}, {"ticker": "VERA", "relevance_score": "0.198221", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYPT", "relevance_score": "0.198221", "ticker_sentiment_score": "0.380827", "ticker_sentiment_label": "Bullish"}, {"ticker": "MNSO", "relevance_score": "0.198221", "ticker_sentiment_score": "0.130414", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBRX", "relevance_score": "0.198221", "ticker_sentiment_score": "0.504895", "ticker_sentiment_label": "Bullish"}, {"ticker": "RVNC", "relevance_score": "0.198221", "ticker_sentiment_score": "0.478266", "ticker_sentiment_label": "Bullish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.198221", "ticker_sentiment_score": "0.156585", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Is Monte Rosa Therapeutics Stock Surging On Monday? - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) , Novartis  ( NYSE:NVS ) ", "url": "https://www.benzinga.com/markets/equities/24/10/41573834/why-is-monte-rosa-therapeutics-stock-surging-on-monday", "time_published": "20241028T124631", "authors": ["Vandana Singh"], "summary": "Monte Rosa Therapeutics Inc GLUE stock is trading higher on Monday after the company announced a global exclusive development and commercialization license agreement with Novartis AG NVS to advance VAV1 MGDs, including MRT-6160.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/28/Genetic-Research-And-Biotech-Science-Con.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.114445, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.409503", "ticker_sentiment_score": "0.246472", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVS", "relevance_score": "0.212115", "ticker_sentiment_score": "0.238556", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Monte Rosa Therapeutics Announces Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders", "url": "https://www.globenewswire.com/news-release/2024/10/28/2969937/0/en/Monte-Rosa-Therapeutics-Announces-Global-License-Agreement-with-Novartis-to-Advance-T-and-B-Cell-modulating-VAV1-directed-Molecular-Glue-Degraders.html", "time_published": "20241028T110000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "Agreement expected to accelerate MRT-6160 clinical development and broadly explore therapeutic opportunities across multiple indications Monte Rosa to receive up-front payment of $150 million and is eligible to receive milestone payments, U.S. profit and loss share, and tiered royalties on ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.071891, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.085122", "ticker_sentiment_score": "0.039886", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences", "url": "https://www.globenewswire.com/news-release/2024/08/28/2936883/0/en/Monte-Rosa-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html", "time_published": "20240828T110000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "BOSTON, Aug. 28, 2024 ( GLOBE NEWSWIRE ) -- ( Nasdaq: GLUE ) , a clinical-stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced that management will participate in the following investor conferences: \u2022 2024 Wells Fargo Healthcare ... ET.", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": -0.158381, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.277433", "ticker_sentiment_score": "-0.192746", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WFC", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.014947", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces First Participants Dosed in MRT-6160 Phase 1 Study", "url": "https://www.globenewswire.com/news-release/2024/08/19/2932006/0/en/Monte-Rosa-Therapeutics-Announces-First-Participants-Dosed-in-MRT-6160-Phase-1-Study.html", "time_published": "20240819T110000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "MRT-6160, a potent and highly selective VAV1-directed molecular glue degrader, represents a potential novel therapeutic approach for systemic and neurological autoimmune and inflammatory diseases", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.062164, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.098255", "ticker_sentiment_score": "-0.025002", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces First Participants Dosed in MRT-6160 Phase 1 Study - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/24/08/g40436843/monte-rosa-therapeutics-announces-first-participants-dosed-in-mrt-6160-phase-1-study", "time_published": "20240819T110000", "authors": ["Globe Newswire"], "summary": "MRT-6160, a potent and highly selective VAV1-directed molecular glue degrader, represents a potential novel therapeutic approach for systemic and neurological autoimmune and inflammatory diseases Initial Phase 1 clinical results, including biomarker data to demonstrate pharmacodynamic effects, ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.048302, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.18602", "ticker_sentiment_score": "-0.035323", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics  ( GLUE )  Reports Q2 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2318897/monte-rosa-therapeutics-glue-reports-q2-loss-tops-revenue-estimates", "time_published": "20240808T121509", "authors": ["Zacks Equity Research"], "summary": "Monte Rosa Therapeutics (GLUE) delivered earnings and revenue surprises of 14% and 46.58%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default318.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.999687"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.123809, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.406745", "ticker_sentiment_score": "0.077349", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.210579", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update", "url": "https://www.globenewswire.com/news-release/2024/08/08/2926748/0/en/Monte-Rosa-Therapeutics-Announces-Second-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html", "time_published": "20240808T110000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "IND clearance achieved for MRT-6160, a VAV1-directed MGD in development for systemic and neurological autoimmune diseases; on track to initiate Phase 1 SAD/MAD study this summer with initial clinical data expected in Q1 2025", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Earnings", "relevance_score": "0.858979"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.031148, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.039811", "ticker_sentiment_score": "0.014754", "ticker_sentiment_label": "Neutral"}]}, {"title": "ADARx Pharmaceuticals Appoints Ajim Tamboli, CFA as Chief Financial Officer", "url": "https://www.benzinga.com/pressreleases/24/07/g40037553/adarx-pharmaceuticals-appoints-ajim-tamboli-cfa-as-chief-financial-officer", "time_published": "20240730T130500", "authors": ["Globe Newswire"], "summary": "SAN DIEGO, July 30, 2024 ( GLOBE NEWSWIRE ) -- ADARx Pharmaceuticals, Inc. ( ADARx ) , a clinical stage biotechnology company developing next generation RNA therapeutics, today announced the appointment of Ajim Tamboli as Chief Financial Officer ( CFO ) .", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.253578, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.066784", "ticker_sentiment_score": "0.123294", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALKS", "relevance_score": "0.066784", "ticker_sentiment_score": "0.123294", "ticker_sentiment_label": "Neutral"}]}, {"title": "Molecular Glues Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight", "url": "https://www.prnewswire.com/news-releases/molecular-glues-clinical-trial-pipeline-appears-robust-with-10-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-302194515.html", "time_published": "20240711T213100", "authors": ["LLP", "DelveInsight Business Research"], "summary": "The molecular glues pipeline and clinical trial analysis report delivers important insights on ongoing research, clinical strategies, upcoming therapeutics, and commercial analysis.", "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.097856, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "JNJ", "relevance_score": "0.024904", "ticker_sentiment_score": "0.028471", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKXJF", "relevance_score": "0.049784", "ticker_sentiment_score": "-0.052735", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARQT", "relevance_score": "0.024904", "ticker_sentiment_score": "0.02309", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNBWF", "relevance_score": "0.024904", "ticker_sentiment_score": "0.02309", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSKYF", "relevance_score": "0.049784", "ticker_sentiment_score": "-0.052735", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.049784", "ticker_sentiment_score": "0.027682", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARA", "relevance_score": "0.024904", "ticker_sentiment_score": "0.02309", "ticker_sentiment_label": "Neutral"}, {"ticker": "APGE", "relevance_score": "0.024904", "ticker_sentiment_score": "0.02309", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEM", "relevance_score": "0.024904", "ticker_sentiment_score": "-0.019809", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.049784", "ticker_sentiment_score": "0.104751", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTHF", "relevance_score": "0.024904", "ticker_sentiment_score": "0.028471", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.074615", "ticker_sentiment_score": "0.106642", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKESF", "relevance_score": "0.024904", "ticker_sentiment_score": "0.02309", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCCC", "relevance_score": "0.024904", "ticker_sentiment_score": "0.028471", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.024904", "ticker_sentiment_score": "0.02309", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALDX", "relevance_score": "0.024904", "ticker_sentiment_score": "0.02309", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.024904", "ticker_sentiment_score": "0.028471", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.049784", "ticker_sentiment_score": "0.031644", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.024904", "ticker_sentiment_score": "-0.102283", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.099373", "ticker_sentiment_score": "-0.001064", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.024904", "ticker_sentiment_score": "0.028471", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYMR", "relevance_score": "0.049784", "ticker_sentiment_score": "0.110774", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSI", "relevance_score": "0.024904", "ticker_sentiment_score": "-0.019809", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRVS", "relevance_score": "0.024904", "ticker_sentiment_score": "0.02309", "ticker_sentiment_label": "Neutral"}, {"ticker": "IOVA", "relevance_score": "0.024904", "ticker_sentiment_score": "-0.019809", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.024904", "ticker_sentiment_score": "0.02309", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.074615", "ticker_sentiment_score": "-0.053652", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIL", "relevance_score": "0.024904", "ticker_sentiment_score": "-0.019809", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNAC", "relevance_score": "0.024904", "ticker_sentiment_score": "0.028471", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.074615", "ticker_sentiment_score": "-0.001011", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVMD", "relevance_score": "0.074615", "ticker_sentiment_score": "0.082227", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYKOF", "relevance_score": "0.024904", "ticker_sentiment_score": "0.02309", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics to Present at the UBS Targeted Protein Degradation Day - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/24/07/g39665134/monte-rosa-therapeutics-to-present-at-the-ubs-targeted-protein-degradation-day", "time_published": "20240708T123657", "authors": ["Globe Newswire"], "summary": "BOSTON, July 08, 2024 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.103154, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.352223", "ticker_sentiment_score": "-0.254629", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Monte Rosa Therapeutics to Present at the UBS Targeted Protein Degradation Day", "url": "https://www.globenewswire.com/news-release/2024/07/08/2909643/0/en/Monte-Rosa-Therapeutics-to-Present-at-the-UBS-Targeted-Protein-Degradation-Day.html", "time_published": "20240708T123600", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "BOSTON, July 08, 2024 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( Nasdaq: GLUE ) , a clinical-stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced that Markus Warmuth, M.D., Chief Executive Officer, will participate in a ... ET.", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.191095, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.407844", "ticker_sentiment_score": "-0.297543", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Monte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis", "url": "https://www.globenewswire.com/news-release/2024/06/14/2898985/0/en/Monte-Rosa-Therapeutics-Presents-Preclinical-Data-at-EULAR-2024-Demonstrating-Therapeutic-Potential-of-MRT-6160-for-the-Treatment-of-Rheumatoid-Arthritis.html", "time_published": "20240614T124500", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "MRT-6160, a VAV1-directed molecular glue degrader ( MGD ) , inhibits disease progression, pro-inflammatory cytokines and autoantibody production in a model of rheumatoid arthritis Initiation of MRT-6160 Phase 1 SAD/MAD study anticipated in mid-year 2024 with initial clinical data expected in Q1 ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.073641, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.139265", "ticker_sentiment_score": "-0.05755", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces Leadership Team Promotions - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/24/05/g39081952/monte-rosa-therapeutics-announces-leadership-team-promotions", "time_published": "20240530T110000", "authors": ["Globe Newswire"], "summary": "BOSTON, May 30, 2024 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. GLUE, a clinical-stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced three leadership team promotions effective immediately: Sharon Townson, Ph.D., to Chief ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.140797, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KYMR", "relevance_score": "0.054983", "ticker_sentiment_score": "0.019", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.217346", "ticker_sentiment_score": "0.017551", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.054983", "ticker_sentiment_score": "0.019", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.054983", "ticker_sentiment_score": "0.184895", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160 in Inflammatory Bowel Disease", "url": "https://www.globenewswire.com/news-release/2024/05/21/2885423/0/en/Monte-Rosa-Therapeutics-Presents-Preclinical-Data-at-Digestive-Disease-Week-2024-Highlighting-Therapeutic-Potential-of-MRT-6160-in-Inflammatory-Bowel-Disease.html", "time_published": "20240521T110000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.047983, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.130358", "ticker_sentiment_score": "-0.028312", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/24/05/g38726371/monte-rosa-therapeutics-announces-first-quarter-2024-financial-results-and-provides-corporate-upda", "time_published": "20240509T110000", "authors": ["Globe Newswire"], "summary": "MRT-2359, a molecular glue degrader ( MGD ) being developed for MYC-driven solid tumors, advancing in ongoing Phase 1/2 clinical trial; determination of recommended Phase 2 dose expected in Q2 2024; Phase 1 clinical data anticipated in H2 2024", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.858979"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.00481, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.069344", "ticker_sentiment_score": "-0.019207", "ticker_sentiment_label": "Neutral"}]}, {"title": "Recent Price Trend in Monte Rosa Therapeutics  ( GLUE )  is Your Friend, Here's Why", "url": "https://www.zacks.com/stock/news/2253147/recent-price-trend-in-monte-rosa-therapeutics-glue-is-your-friend-heres-why", "time_published": "20240410T125005", "authors": ["Zacks Equity Research"], "summary": "Monte Rosa Therapeutics (GLUE) made it through our \"Recent Price Strength\" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default85.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999612"}], "overall_sentiment_score": 0.3855, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.420316", "ticker_sentiment_score": "0.386716", "ticker_sentiment_label": "Bullish"}]}, {"title": "Does Monte Rosa Therapeutics  ( GLUE )  Have the Potential to Rally 107.79% as Wall Street Analysts Expect?", "url": "https://www.zacks.com/stock/news/2250505/does-monte-rosa-therapeutics-glue-have-the-potential-to-rally-10779-as-wall-street-analysts-expect", "time_published": "20240404T135506", "authors": ["Zacks Equity Research"], "summary": "The consensus price target hints at a 107.8% upside potential for Monte Rosa Therapeutics (GLUE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default125.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.258686, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.285526", "ticker_sentiment_score": "0.367514", "ticker_sentiment_label": "Bullish"}]}, {"title": "Monte Rosa Therapeutics  ( GLUE )  Is a Great Choice for 'Trend' Investors, Here's Why", "url": "https://www.zacks.com/stock/news/2244669/monte-rosa-therapeutics-glue-is-a-great-choice-for-trend-investors-heres-why", "time_published": "20240322T125008", "authors": ["Zacks Equity Research"], "summary": "Monte Rosa Therapeutics (GLUE) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our \"Recent Price Strength\" screen.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default239.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999612"}], "overall_sentiment_score": 0.380083, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.421485", "ticker_sentiment_score": "0.387385", "ticker_sentiment_label": "Bullish"}]}, {"title": "Wall Street Analysts Predict an 117.91% Upside in Monte Rosa Therapeutics  ( GLUE ) : Here's What You Should Know", "url": "https://www.zacks.com/stock/news/2242850/wall-street-analysts-predict-an-11791-upside-in-monte-rosa-therapeutics-glue-heres-what-you-should-know", "time_published": "20240319T135505", "authors": ["Zacks Equity Research"], "summary": "The mean of analysts' price targets for Monte Rosa Therapeutics (GLUE) points to an 117.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default344.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.231528, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.284861", "ticker_sentiment_score": "0.304053", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update", "url": "https://www.globenewswire.com/news-release/2024/03/14/2846136/0/en/Monte-Rosa-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html", "time_published": "20240314T110000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "MRT-2359, a molecular glue degrader ( MGD ) being developed for MYC-driven solid tumors, advancing in ongoing Phase 1/2 clinical trial; program on track with determination of recommended Phase 2 dose expected in Q2 2024", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.038295, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.070269", "ticker_sentiment_score": "0.018245", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces Initiation of IND Enabling Studies for MRT-8102, A First-in-Class NEK7 Directed Molecular Glue Degrader and NLRP3/IL-1\u03b2 Pathway Inhibitor", "url": "https://www.globenewswire.com/news-release/2024/03/11/2843611/0/en/Monte-Rosa-Therapeutics-Announces-Initiation-of-IND-Enabling-Studies-for-MRT-8102-A-First-in-Class-NEK7-Directed-Molecular-Glue-Degrader-and-NLRP3-IL-1%CE%B2-Pathway-Inhibitor.html", "time_published": "20240311T110000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "Monte Rosa Therapeutics Announces Initiation of IND Enabling Studies for MRT-8102, A First-in-Class NEK7-Directed Molecular Glue Degrader ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.06453, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.096412", "ticker_sentiment_score": "-0.051695", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Is Monte Rosa Therapeutics Stock Trading Higher Today? - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37165587/monte-rosa-therapeutics-ai-and-machine-learning-platform-is-adding-significant-valu", "time_published": "20240215T190511", "authors": ["Vandana Singh"], "summary": "Wedbush initiated coverage on Monte Rosa Therapeutics Inc GLUE, a company focused on developing molecular glue degraders ( MGDs ) against several inadequately drugged cancer and autoimmune disease targets.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/cancer_8.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.147539, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.756001", "ticker_sentiment_score": "-0.182609", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street", "url": "https://www.fool.com/investing/2024/01/16/3-incredible-growth-stocks-that-could-soar-in-2024/", "time_published": "20240116T140000", "authors": ["George Budwell"], "summary": "Analysts have high hopes for these three innovation companies in 2024.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F761356%2Fgrowth-graph.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.150673, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BEAM", "relevance_score": "0.172919", "ticker_sentiment_score": "0.172542", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GLUE", "relevance_score": "0.172919", "ticker_sentiment_score": "0.039127", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWTX", "relevance_score": "0.172919", "ticker_sentiment_score": "0.094947", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.058047", "ticker_sentiment_score": "-0.027038", "ticker_sentiment_label": "Neutral"}]}, {"title": "Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates DelveInsight | Key Players - Eli Lilly and Company, Phanes Therapeutics, Camurus AB, Advanced Accelerator Applications, PharmaMar", "url": "https://www.prnewswire.com/news-releases/gastroenteropancreatic-neuroendocrine-tumors-market-to-showcase-a-significant-growth-by-2032-evaluates-delveinsight--key-players---eli-lilly-and-company-phanes-therapeutics-camurus-ab-advanced-accelerator-applications-pharma-302032286.html", "time_published": "20240111T220100", "authors": ["LLP", "DelveInsight Business Research"], "summary": "Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.229158, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BTAI", "relevance_score": "0.025139", "ticker_sentiment_score": "0.05757", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASPHF", "relevance_score": "0.025139", "ticker_sentiment_score": "0.019544", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRNX", "relevance_score": "0.025139", "ticker_sentiment_score": "0.019544", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHMMF", "relevance_score": "0.050254", "ticker_sentiment_score": "0.093442", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYZB", "relevance_score": "0.075318", "ticker_sentiment_score": "0.082786", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLRPF", "relevance_score": "0.025139", "ticker_sentiment_score": "0.019544", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.075318", "ticker_sentiment_score": "0.02929", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.025139", "ticker_sentiment_score": "0.034515", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCM", "relevance_score": "0.025139", "ticker_sentiment_score": "0.05757", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.025139", "ticker_sentiment_score": "0.05757", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAZZ", "relevance_score": "0.025139", "ticker_sentiment_score": "0.019544", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.025139", "ticker_sentiment_score": "0.019544", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.025139", "ticker_sentiment_score": "0.05757", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXEL", "relevance_score": "0.075318", "ticker_sentiment_score": "0.041398", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUJIF", "relevance_score": "0.025139", "ticker_sentiment_score": "0.019544", "ticker_sentiment_label": "Neutral"}, {"ticker": "AADI", "relevance_score": "0.025139", "ticker_sentiment_score": "0.106773", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.025139", "ticker_sentiment_score": "0.034515", "ticker_sentiment_label": "Neutral"}]}, {"title": "Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday - Aehr Test Systems  ( NASDAQ:AEHR ) , Arcadium Lithium  ( NYSE:ALTM ) ", "url": "https://www.benzinga.com/news/24/01/36578224/veradigm-aehr-test-systems-saratoga-investment-and-other-big-stocks-moving-lower-on-wednesday", "time_published": "20240110T152708", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. MDRX shares fell sharply during Wednesday's session. Veradigm said it sees FY23 revenue of $608 million to $622 million. The company also sees FY23 Non-GAAP EPS of 79 cents ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/10/image36.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.967645"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.281452, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "DDD", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.565018", "ticker_sentiment_label": "Bearish"}, {"ticker": "SHJBF", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.035472", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAF", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.144651", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSL", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.39376", "ticker_sentiment_label": "Bearish"}, {"ticker": "COIN", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.143503", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEHR", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.027741", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGTX", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.217288", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MIRM", "relevance_score": "0.309539", "ticker_sentiment_score": "-0.322224", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NVCR", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.379004", "ticker_sentiment_label": "Bearish"}, {"ticker": "GLUE", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.565018", "ticker_sentiment_label": "Bearish"}, {"ticker": "DCGO", "relevance_score": "0.209365", "ticker_sentiment_score": "0.015242", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLRY", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.167159", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CHRS", "relevance_score": "0.309539", "ticker_sentiment_score": "-0.072985", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.565018", "ticker_sentiment_label": "Bearish"}, {"ticker": "MDRX", "relevance_score": "0.404563", "ticker_sentiment_score": "-0.077608", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALTM", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.565018", "ticker_sentiment_label": "Bearish"}, {"ticker": "WOLF", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.565018", "ticker_sentiment_label": "Bearish"}, {"ticker": "UP", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.408116", "ticker_sentiment_label": "Bearish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.095484", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2024 - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36530692/monte-rosa-therapeutics-provides-corporate-update-and-key-anticipated-milestones-for-2024", "time_published": "20240108T121500", "authors": ["Globe Newswire"], "summary": "Phase 1/2 clinical trial of MRT-2359 in MYC-driven solid tumors on track; recommended Phase 2 dose ( RP2D ) expected in Q2 2024 Received US FDA Fast Track Designation for MRT-2359 for previously treated, metastatic small cell lung cancer with L- or N-MYC expression", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.007229, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.151922", "ticker_sentiment_score": "-0.012067", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2024", "url": "https://www.globenewswire.com/news-release/2024/01/08/2805310/0/en/Monte-Rosa-Therapeutics-Provides-Corporate-Update-and-Key-Anticipated-Milestones-for-2024.html", "time_published": "20240108T121500", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.021621, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.107303", "ticker_sentiment_score": "0.005593", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics to Present at Piper Sandler Healthcare Conference - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35891039/monte-rosa-therapeutics-to-present-at-piper-sandler-healthcare-conference", "time_published": "20231121T120000", "authors": ["Globe Newswire"], "summary": "BOSTON, Nov. 21, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, a clinical-stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced that management will participate in a fireside discussion at the 35th Annual Piper Sandler Healthcare ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.151177, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.271274", "ticker_sentiment_score": "-0.18937", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2023 Demonstrating Potential of MRT-6160, a VAV1-targeted Molecular Glue Degrader, to Treat Immunological and Inflammatory Diseases", "url": "https://www.globenewswire.com/news-release/2023/11/07/2775281/0/en/Monte-Rosa-Therapeutics-Presents-Preclinical-Data-at-ACR-Convergence-2023-Demonstrating-Potential-of-MRT-6160-a-VAV1-targeted-Molecular-Glue-Degrader-to-Treat-Immunological-and-Inf.html", "time_published": "20231107T150000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2023 Demonstrating Potential of MRT-6160, a VAV1-targeted Molecular Glue Degrader, to ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.060091, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.136693", "ticker_sentiment_score": "-0.028977", "ticker_sentiment_label": "Neutral"}]}, {"title": "BD  ( BDX )  Gears Up for Q4 Earnings: What's in the Offing?", "url": "https://www.zacks.com/stock/news/2179234/bd-bdx-gears-up-for-q4-earnings-whats-in-the-offing", "time_published": "20231106T144800", "authors": ["Zacks Equity Research"], "summary": "Continued strength in BD's (BDX) Life Sciences segment's base business is expected to have benefited fiscal fourth-quarter sales.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/dd/52606.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.259353, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HQY", "relevance_score": "0.103628", "ticker_sentiment_score": "0.066434", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.103628", "ticker_sentiment_score": "0.097676", "ticker_sentiment_label": "Neutral"}, {"ticker": "STE", "relevance_score": "0.03463", "ticker_sentiment_score": "0.171329", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OM", "relevance_score": "0.103628", "ticker_sentiment_score": "0.091204", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.137868", "ticker_sentiment_score": "0.106407", "ticker_sentiment_label": "Neutral"}]}, {"title": "DaVita  ( DVA )  to Report Q3 Earnings: What's in the Offing?", "url": "https://www.zacks.com/stock/news/2178305/davita-dva-to-report-q3-earnings-whats-in-the-offing", "time_published": "20231103T172100", "authors": ["Zacks Equity Research"], "summary": "Improvement in U.S. dialysis treatments per day and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the third quarter.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/dd/52606.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.302011, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BEAM", "relevance_score": "0.222838", "ticker_sentiment_score": "0.068799", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.168099", "ticker_sentiment_score": "0.124117", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.056407", "ticker_sentiment_score": "0.282004", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DVA", "relevance_score": "0.520773", "ticker_sentiment_score": "0.522152", "ticker_sentiment_label": "Bullish"}, {"ticker": "SWAV", "relevance_score": "0.168099", "ticker_sentiment_score": "0.12001", "ticker_sentiment_label": "Neutral"}]}, {"title": "DaVita  ( DVA )  to Report Q3 Earnings: What's in the Offing?", "url": "https://www.zacks.com/stock/news/2178305/davita-dva-to-report-q3-earnings-whats-in-the-offing", "time_published": "20231103T162100", "authors": ["Zacks Equity Research"], "summary": "Improvement in U.S. dialysis treatments per day and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the third quarter.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/dd/52606.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.302011, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BEAM", "relevance_score": "0.222838", "ticker_sentiment_score": "0.068799", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.168099", "ticker_sentiment_score": "0.124117", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.056407", "ticker_sentiment_score": "0.282004", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DVA", "relevance_score": "0.520773", "ticker_sentiment_score": "0.522152", "ticker_sentiment_label": "Bullish"}, {"ticker": "SWAV", "relevance_score": "0.168099", "ticker_sentiment_score": "0.12001", "ticker_sentiment_label": "Neutral"}]}, {"title": "Lantheus  ( LNTH )  to Report Q3 Earnings: What's in the Cards?", "url": "https://www.zacks.com/stock/news/2176580/lantheus-lnth-to-report-q3-earnings-whats-in-the-cards", "time_published": "20231101T155900", "authors": ["Zacks Equity Research"], "summary": "Lantheus' (LNTH) third-quarter results are likely to reflect solid top-line performance on the back of robust product adoption.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6e/54381.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999998"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.235363, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.158868", "ticker_sentiment_score": "0.081346", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.158868", "ticker_sentiment_score": "0.119603", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNTH", "relevance_score": "0.577321", "ticker_sentiment_score": "0.421542", "ticker_sentiment_label": "Bullish"}, {"ticker": "SWAV", "relevance_score": "0.158868", "ticker_sentiment_score": "0.115643", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences", "url": "https://www.globenewswire.com/news-release/2023/10/27/2768275/0/en/Monte-Rosa-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html", "time_published": "20231027T110000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "BOSTON, Oct. 27, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, a clinical-stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced that management will participate in the following investor conferences:", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.12171, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.340915", "ticker_sentiment_score": "-0.20103", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35451592/monte-rosa-therapeutics-announces-25-million-registered-direct-offering-priced-at-the-market-under", "time_published": "20231026T203050", "authors": ["Globe Newswire"], "summary": "BOSTON, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. GLUE, a clinical-stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced that it has raised $25 million at-the-market from a life sciences-dedicated investor.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.839681"}], "overall_sentiment_score": 0.042788, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.2256", "ticker_sentiment_score": "-0.131435", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules", "url": "https://www.globenewswire.com/news-release/2023/10/26/2768049/0/en/Monte-Rosa-Therapeutics-Announces-25-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html", "time_published": "20231026T203000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "BOSTON, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- ( Nasdaq: GLUE ) , a clinical-stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced that it has raised $25 million at-the-market from a life sciences-dedicated investor.", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.875462"}], "overall_sentiment_score": 0.016668, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.0864", "ticker_sentiment_score": "-0.083486", "ticker_sentiment_label": "Neutral"}]}, {"title": "Down -56.34% in 4 Weeks, Here's Why You Should You Buy the Dip in Monte Rosa Therapeutics  ( GLUE ) ", "url": "https://www.zacks.com/stock/news/2170790/down--5634-in-4-weeks-heres-why-you-should-you-buy-the-dip-in-monte-rosa-therapeutics-glue", "time_published": "20231024T133506", "authors": ["Zacks Equity Research"], "summary": "Monte Rosa Therapeutics (GLUE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default57.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}], "overall_sentiment_score": 0.154877, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.493128", "ticker_sentiment_score": "0.178947", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Crude Oil Moves Lower; Bank of America Profit Beats Expectations - Bank of America  ( NYSE:BAC ) , Assembly Biosciences  ( NASDAQ:ASMB ) ", "url": "https://www.benzinga.com/news/earnings/23/10/35295744/crude-oil-moves-lower-bank-of-america-profit-beats-expectations", "time_published": "20231017T183154", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.09% to 33,954.39 while the NASDAQ fell 0.37% to 13,517.59. The S&P 500 also fell, dropping, 0.10% to 4,369.41. Materials shares climbed by 1% on Tuesday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/17/image16.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.055502, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NTCT", "relevance_score": "0.132368", "ticker_sentiment_score": "-0.009001", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.132368", "ticker_sentiment_score": "0.339911", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EVLO", "relevance_score": "0.197413", "ticker_sentiment_score": "0.145394", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.132368", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.066414", "ticker_sentiment_score": "-0.245957", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TMO", "relevance_score": "0.066414", "ticker_sentiment_score": "0.238904", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SPRC", "relevance_score": "0.197413", "ticker_sentiment_score": "0.220077", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ASMB", "relevance_score": "0.132368", "ticker_sentiment_score": "0.230699", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OLK", "relevance_score": "0.132368", "ticker_sentiment_score": "0.283099", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Dow Surges 100 Points; Goldman Sachs Posts Upbeat Earnings - Evelo Biosciences  ( NASDAQ:EVLO ) , Assembly Biosciences  ( NASDAQ:ASMB ) ", "url": "https://www.benzinga.com/news/earnings/23/10/35292651/dow-surges-100-points-goldman-sachs-posts-upbeat-earnings", "time_published": "20231017T155630", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded mostly higher midway through trading, with the Dow Jones falling gaining around 100 points on Tuesday. The Dow traded up 0.31% to 34,090.15 while the NASDAQ fell 0.05% to 13,560.52. The S&P 500 also rose, gaining, 0.25% to 4,384.43.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/17/crude_oil_6-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.086864, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NTCT", "relevance_score": "0.132004", "ticker_sentiment_score": "-0.008987", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVLO", "relevance_score": "0.196877", "ticker_sentiment_score": "0.145097", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.132004", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.06623", "ticker_sentiment_score": "-0.245922", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TMO", "relevance_score": "0.06623", "ticker_sentiment_score": "0.238871", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SPRC", "relevance_score": "0.196877", "ticker_sentiment_score": "0.219638", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ASMB", "relevance_score": "0.132004", "ticker_sentiment_score": "0.230389", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GS", "relevance_score": "0.132004", "ticker_sentiment_score": "0.339475", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OLK", "relevance_score": "0.132004", "ticker_sentiment_score": "0.282726", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "What's Going On Cancer Player Monte Rosa Therapeutics Stock Today? - Roche Holding  ( OTC:RHHBF ) , Monte Rosa Therapeutics  ( NASDAQ:GLUE ) , Roche Holding  ( OTC:RHHVF ) , Roche Holding  ( OTC:RHHBY ) ", "url": "https://www.benzinga.com/general/biotech/23/10/35288868/whats-going-on-cancer-player-monte-rosa-therapeutics-stock-today", "time_published": "20231017T151351", "authors": ["Vandana Singh"], "summary": "Monte Rosa Therapeutics Inc GLUE entered into a strategic collaboration and licensing agreement with Roche Holdings AG RHHBY to discover and develop molecular glue degraders ( MGDs ) against targets in cancer and neurological diseases.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/17/glue.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.173259, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.423251", "ticker_sentiment_score": "-0.162511", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Monte Rosa Therapeutics Announces Strategic Collaboration with Roche to Discover Novel Molecular Glue Degraders Targeting Cancer and Neurological Diseases", "url": "https://www.globenewswire.com/news-release/2023/10/17/2761334/0/en/Monte-Rosa-Therapeutics-Announces-Strategic-Collaboration-with-Roche-to-Discover-Novel-Molecular-Glue-Degraders-Targeting-Cancer-and-Neurological-Diseases.html", "time_published": "20231017T110000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "Collaboration combines Monte Rosa Therapeutics' highly differentiated QuEENTM discovery engine with Roche's strong expertise in delivering transformative therapies to patients Monte Rosa to receive an upfront payment of $50 million and potential future payments exceeding $2 billion", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.083643, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.210884", "ticker_sentiment_score": "0.100154", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces Interim PK/PD and Clinical Data for MRT-2359 in Phase 1/2 Trial for MYC-Driven Solid Tumors", "url": "https://www.globenewswire.com/news-release/2023/10/17/2761331/0/en/Monte-Rosa-Therapeutics-Announces-Interim-PK-PD-and-Clinical-Data-for-MRT-2359-in-Phase-1-2-Trial-for-MYC-Driven-Solid-Tumors.html", "time_published": "20231017T110000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "Optimal levels of degradation of GSPT1 in peripheral blood mononuclear cells and tumors observed at all doses, consistent with preclinical studies Conference call and webcast at 8:00 a.m. ET today", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Blockchain", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.06499, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.13459", "ticker_sentiment_score": "0.040992", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces Interim PK/PD and Clinical Data for MRT-2359 in Phase 1/2 Trial for MYC-Driven Solid Tumors - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35283477/monte-rosa-therapeutics-announces-interim-pkpd-and-clinical-data-for-mrt-2359-in-phase-12-trial-fo", "time_published": "20231017T110000", "authors": ["Globe Newswire"], "summary": "Optimal levels of degradation of GSPT1 in peripheral blood mononuclear cells and tumors observed at all doses, consistent with preclinical studies Tumor size reductions observed in patients with biomarker-positive tumors Safety profile supports further clinical development of MRT-2359", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Blockchain", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.064912, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.112709", "ticker_sentiment_score": "0.039929", "ticker_sentiment_label": "Neutral"}]}, {"title": "Arbor Biotechnologies Appoints Ajim Tamboli as Chief Financial Officer", "url": "https://www.benzinga.com/pressreleases/23/08/g34084969/arbor-biotechnologies-appoints-ajim-tamboli-as-chief-financial-officer", "time_published": "20230829T110000", "authors": ["Globe Newswire"], "summary": "CAMBRIDGE, Mass., Aug. 29, 2023 ( GLOBE NEWSWIRE ) -- Arbor Biotechnologies\u00ae, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Ajim Tamboli, CFA, as its Chief Financial Officer.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.276665, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.143415", "ticker_sentiment_score": "0.133597", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALKS", "relevance_score": "0.072", "ticker_sentiment_score": "0.127872", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.072", "ticker_sentiment_score": "0.197647", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Monte Rosa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update", "url": "https://www.globenewswire.com/news-release/2023/08/10/2722527/0/en/Monte-Rosa-Therapeutics-Announces-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html", "time_published": "20230810T111500", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "BOSTON, Aug. 10, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( Nasdaq: GLUE ) , a clinical-stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today reported business highlights and financial results for the quarter ended June 30, 2023.", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.019313, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.069361", "ticker_sentiment_score": "-0.006123", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Appoints Dr. Anthony M. Manning to Board of Directors - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/23/07/g33389178/monte-rosa-therapeutics-appoints-dr-anthony-m-manning-to-board-of-directors", "time_published": "20230726T113000", "authors": ["Globe Newswire"], "summary": "BOSTON, July 26, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. GLUE, a clinical stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the appointment of Anthony M. Manning, Ph.D., to its Board of Directors.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.09384, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.272788", "ticker_sentiment_score": "0.069074", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.069495", "ticker_sentiment_score": "0.074263", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.069495", "ticker_sentiment_score": "0.074263", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Appoints Dr. Anthony M. Manning to Board of Directors", "url": "https://www.globenewswire.com/news-release/2023/07/26/2711202/0/en/Monte-Rosa-Therapeutics-Appoints-Dr-Anthony-M-Manning-to-Board-of-Directors.html", "time_published": "20230726T113000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "BOSTON, July 26, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( NASDAQ: GLUE ) , a clinical stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the appointment of Anthony M. Manning, Ph.D., to its Board of Directors.", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.060082, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.182506", "ticker_sentiment_score": "-0.029393", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.046006", "ticker_sentiment_score": "0.072788", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.046006", "ticker_sentiment_score": "0.072788", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics to Present at Upcoming Investor and Industry Conferences", "url": "https://www.globenewswire.com/news-release/2023/05/30/2678856/0/en/Monte-Rosa-Therapeutics-to-Present-at-Upcoming-Investor-and-Industry-Conferences.html", "time_published": "20230530T203000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "BOSTON, May 30, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( Nasdaq: GLUE ) , a clinical-stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the company is scheduled to present at the following investor and industry events ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.043396, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.470894", "ticker_sentiment_score": "-0.129423", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update", "url": "https://www.globenewswire.com/news-release/2023/05/11/2666597/0/en/Monte-Rosa-Therapeutics-Announces-First-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html", "time_published": "20230511T113000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "BOSTON, May 11, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( Nasdaq: GLUE ) , a clinical-stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today reported business highlights and financial results for the quarter ended March 31, 2023.", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.03859, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.074153", "ticker_sentiment_score": "-0.110401", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Presents Preclinical Data from GSPT1 Degrader Program Focused on MYC-Driven Cancers at AACR 2023", "url": "https://www.globenewswire.com/news-release/2023/04/17/2648480/0/en/Monte-Rosa-Therapeutics-Presents-Preclinical-Data-from-GSPT1-Degrader-Program-Focused-on-MYC-Driven-Cancers-at-AACR-2023.html", "time_published": "20230417T203000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "BOSTON, April 17, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( NASDAQ: GLUE ) , a clinical stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today presented preclinical data characterizing MRT-2359, an orally bioavailable GSPT1-directed ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.133296, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.094266", "ticker_sentiment_score": "-0.132009", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/23/03/g31471796/monte-rosa-therapeutics-appoints-dr-jan-skvarka-to-board-of-directors", "time_published": "20230323T113000", "authors": ["Globe Newswire"], "summary": "BOSTON, March 23, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. GLUE, a clinical stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the appointment of Jan Skvarka, Ph.D., MBA to its Board of Directors.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.151555, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.144708", "ticker_sentiment_score": "0.043301", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.072655", "ticker_sentiment_score": "0.07548", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTL", "relevance_score": "0.072655", "ticker_sentiment_score": "0.07548", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors", "url": "https://www.globenewswire.com/news-release/2023/03/23/2633019/0/en/Monte-Rosa-Therapeutics-Appoints-Dr-Jan-Skvarka-to-Board-of-Directors.html", "time_published": "20230323T113000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "BOSTON, March 23, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( NASDAQ: GLUE ) , a clinical stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the appointment of Jan Skvarka, Ph.D., MBA to its Board of Directors.", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.083426, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.143131", "ticker_sentiment_score": "-0.072305", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.04794", "ticker_sentiment_score": "0.074087", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTL", "relevance_score": "0.04794", "ticker_sentiment_score": "0.074087", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update", "url": "https://www.globenewswire.com/news-release/2023/03/16/2628536/0/en/Monte-Rosa-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html", "time_published": "20230316T113000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "BOSTON, March 16, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( NASDAQ: GLUE ) , a clinical stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today reported financial results for the fourth quarter and full year ended December 31, 2022, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.093109, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.060035", "ticker_sentiment_score": "-0.081229", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics to Present at Upcoming Investor Conferences", "url": "https://www.globenewswire.com/news-release/2023/02/03/2601254/0/en/Monte-Rosa-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html", "time_published": "20230203T123000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "BOSTON, Feb. 03, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( NASDAQ: GLUE ) , a biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the company is scheduled to participate in fireside chats and industry panels, as well as ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.007252, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.43852", "ticker_sentiment_score": "-0.065134", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics to Present at Upcoming Investor Conferences - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/23/02/g30704859/monte-rosa-therapeutics-to-present-at-upcoming-investor-conferences", "time_published": "20230203T123000", "authors": ["Globe Newswire"], "summary": "BOSTON, Feb. 03, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. GLUE, a biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the company is scheduled to participate in fireside chats and industry panels, as well as present at the ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": -0.033676, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.268294", "ticker_sentiment_score": "0.054719", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.136113", "ticker_sentiment_score": "-0.26654", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "How Much Upside is Left in Monte Rosa Therapeutics  ( GLUE ) ? Wall Street Analysts Think 226.46%", "url": "https://www.zacks.com/stock/news/2044092/how-much-upside-is-left-in-monte-rosa-therapeutics-glue-wall-street-analysts-think-22646", "time_published": "20230125T145508", "authors": ["Zacks Investment Research"], "summary": "The mean of analysts' price targets for Monte Rosa Therapeutics (GLUE) points to a 226.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default276.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.208885, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.282886", "ticker_sentiment_score": "0.302462", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Monte Rosa Therapeutics Outlines Progress Across Portfolio of Molecular Glue Degraders and Key Anticipated Milestones for 2023 - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/23/01/g30330274/monte-rosa-therapeutics-outlines-progress-across-portfolio-of-molecular-glue-degraders-and-key-ant", "time_published": "20230109T123000", "authors": ["Globe Newswire"], "summary": "MRT-2359 received Fast Track designation from the FDA for the treatment of patients with previously treated, metastatic non-small cell lung cancer ( NSCLC ) with L-MYC or N-MYC expression Disclosure of initial data from Phase 1 arm of ongoing Phase 1/2 clinical trial evaluating MRT-2359 ...", "banner_image": "", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.004825, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.09402", "ticker_sentiment_score": "0.005308", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Outlines Progress Across Portfolio of Molecular Glue Degraders and Key Anticipated Milestones for 2023", "url": "https://www.globenewswire.com/news-release/2023/01/09/2585095/0/en/Monte-Rosa-Therapeutics-Outlines-Progress-Across-Portfolio-of-Molecular-Glue-Degraders-and-Key-Anticipated-Milestones-for-2023.html", "time_published": "20230109T123000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "BOSTON, Jan. 09, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( NASDAQ: GLUE ) , a biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today outlined anticipated 2023 milestones ahead of its participation at the 41st Annual J.P.", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.043209, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.090931", "ticker_sentiment_score": "-0.052996", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2023/01/04/2582790/0/en/Monte-Rosa-Therapeutics-to-Present-at-the-41st-Annual-J-P-Morgan-Healthcare-Conference.html", "time_published": "20230104T123000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "BOSTON, Jan. 04, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( NASDAQ: GLUE ) , a biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced that Markus Warmuth, M.D., Chief Executive Officer, is scheduled to present at the 41st Annual ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.069255, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.479683", "ticker_sentiment_score": "-0.175488", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Dow Surges 150 Points; Crude Oil Falls Sharply - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) , Freight Technologies  ( NASDAQ:FRGT ) ", "url": "https://www.benzinga.com/news/earnings/22/11/29710122/dow-surges-150-points-crude-oil-falls-sharply", "time_published": "20221114T193407", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday. The Dow traded up 0.45% to 33,898.95 while the NASDAQ rose 0.11% to 11,335.52. The S&P 500 also rose, gaining, 0.30% to 4,004.81.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/11/14/image38.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.223913, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TBLT", "relevance_score": "0.136113", "ticker_sentiment_score": "0.449036", "ticker_sentiment_label": "Bullish"}, {"ticker": "OPNT", "relevance_score": "0.202932", "ticker_sentiment_score": "0.442572", "ticker_sentiment_label": "Bullish"}, {"ticker": "GLUE", "relevance_score": "0.136113", "ticker_sentiment_score": "0.512915", "ticker_sentiment_label": "Bullish"}, {"ticker": "LNTH", "relevance_score": "0.068306", "ticker_sentiment_score": "0.076836", "ticker_sentiment_label": "Neutral"}, {"ticker": "PDSB", "relevance_score": "0.136113", "ticker_sentiment_score": "0.512915", "ticker_sentiment_label": "Bullish"}, {"ticker": "PNT", "relevance_score": "0.136113", "ticker_sentiment_score": "0.094732", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGT", "relevance_score": "0.136113", "ticker_sentiment_score": "0.204916", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STSA", "relevance_score": "0.136113", "ticker_sentiment_score": "-0.036476", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.136113", "ticker_sentiment_score": "0.11898", "ticker_sentiment_label": "Neutral"}, {"ticker": "IZQVF", "relevance_score": "0.068306", "ticker_sentiment_score": "0.292851", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSN", "relevance_score": "0.268294", "ticker_sentiment_score": "-0.078098", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating MRT-2359, a GSPT1-directed Molecular Glue Degrader, for Treatment of MYC-driven Tumors - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/22/11/g29497407/monte-rosa-therapeutics-announces-first-patient-dosed-in-phase-12-clinical-trial-evaluating-mrt-23", "time_published": "20221101T113000", "authors": ["Globe Newswire"], "summary": "BOSTON, Nov. 01, 2022 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. GLUE, a biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the company has dosed the first patient in its Phase 1/2 clinical trial evaluating MRT-2359 for the treatment ...", "banner_image": "", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.00244, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.120733", "ticker_sentiment_score": "0.007243", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces Participation in Upcoming Investor Conferences", "url": "https://www.globenewswire.com/news-release/2022/10/31/2545013/0/en/Monte-Rosa-Therapeutics-Announces-Participation-in-Upcoming-Investor-Conferences.html", "time_published": "20221031T203000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "BOSTON, Oct. 31, 2022 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( NASDAQ: GLUE ) , a biotechnology company developing novel molecular glue degrader-based medicines, today announced the company will participate in the following upcoming investor conferences: ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.097326, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.539306", "ticker_sentiment_score": "-0.149432", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Announces Participation in Upcoming Investor Conferences - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/22/10/g29489231/monte-rosa-therapeutics-announces-participation-in-upcoming-investor-conferences", "time_published": "20221031T203000", "authors": ["Globe Newswire"], "summary": "BOSTON, Oct. 31, 2022 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. GLUE, a biotechnology company developing novel molecular glue degrader-based medicines, today announced the company will participate in the following upcoming investor conferences:", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.078305, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.305058", "ticker_sentiment_score": "0.1493", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics to Present at 5th Annual Targeted Protein Degradation Summit and 34th EORTC-NCI-AACR Symposium", "url": "https://www.globenewswire.com/news-release/2022/10/20/2538856/0/en/Monte-Rosa-Therapeutics-to-Present-at-5th-Annual-Targeted-Protein-Degradation-Summit-and-34th-EORTC-NCI-AACR-Symposium.html", "time_published": "20221020T203000", "authors": ["Monte Rosa Therapeutics", "Inc."], "summary": "- New and Updated Preclinical Data Highlight Potential of GSPT1-directed Molecular Glue Degrader ( MGD ) MRT-2359 in the Treatment of MYC-driven Cancers ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.094266", "ticker_sentiment_score": "-0.060008", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics to Present at 5th Annual Targeted Protein Degradation Summit and 34th EORTC-NCI-AACR Symposium - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ", "url": "https://www.benzinga.com/pressreleases/22/10/g29350723/monte-rosa-therapeutics-to-present-at-5th-annual-targeted-protein-degradation-summit-and-34th-eort", "time_published": "20221020T203000", "authors": ["Globe Newswire"], "summary": "BOSTON, Oct. 20, 2022 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.02922, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.107255", "ticker_sentiment_score": "-0.032569", "ticker_sentiment_label": "Neutral"}]}, {"title": "5 Value Stocks In The Healthcare Sector - Baudax Bio  ( NASDAQ:BXRX ) , Monte Rosa Therapeutics  ( NASDAQ:GLUE ) , HCA Healthcare  ( NYSE:HCA ) , Lyell Immunopharma  ( NASDAQ:LYEL ) , Aerovate Therapeutics  ( NASDAQ:AVTE ) ", "url": "https://www.benzinga.com/news/22/10/29289923/5-value-stocks-in-the-healthcare-sector", "time_published": "20221017T144630", "authors": ["Benzinga Insights"], "summary": "A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/valuestock_image_3292.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.998626"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}], "overall_sentiment_score": 0.392845, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "AVTE", "relevance_score": "0.199037", "ticker_sentiment_score": "0.235102", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BXRX", "relevance_score": "0.199037", "ticker_sentiment_score": "0.235102", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GLUE", "relevance_score": "0.199037", "ticker_sentiment_score": "0.286395", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HCA", "relevance_score": "0.199037", "ticker_sentiment_score": "0.286395", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LYEL", "relevance_score": "0.199037", "ticker_sentiment_score": "0.286395", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Albertsons Companies, Domino's Pizza And Other Big Gainers From Thursday - Albertsons Companies  ( NYSE:ACI ) , ACM Research  ( NASDAQ:ACMR ) ", "url": "https://www.benzinga.com/news/22/10/29264677/albertsons-companies-dominos-pizza-and-other-big-gainers-from-thursday", "time_published": "20221014T064641", "authors": ["Lisa Levin"], "summary": "U.S. stocks closed higher on Thursday, with the Dow Jones jumping over 800 points. Here is the list of some big stocks recording gains in the previous session. Nutex Health Inc. NUTX jumped 72.4% to settle at $0.9551 on Thursday. Nutex Health recently provided a corporate update.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/10/14/image26.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.928769"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.277848, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.137671", "ticker_sentiment_score": "0.367879", "ticker_sentiment_label": "Bullish"}, {"ticker": "SVC", "relevance_score": "0.205225", "ticker_sentiment_score": "0.37821", "ticker_sentiment_label": "Bullish"}, {"ticker": "VORB", "relevance_score": "0.137671", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACI", "relevance_score": "0.137671", "ticker_sentiment_score": "-0.105111", "ticker_sentiment_label": "Neutral"}, {"ticker": "VECT", "relevance_score": "0.137671", "ticker_sentiment_score": "0.139162", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAK", "relevance_score": "0.137671", "ticker_sentiment_score": "0.32842", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DAL", "relevance_score": "0.137671", "ticker_sentiment_score": "0.06872", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXSM", "relevance_score": "0.137671", "ticker_sentiment_score": "0.0838", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.137671", "ticker_sentiment_score": "0.338017", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NUTX", "relevance_score": "0.205225", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUDI", "relevance_score": "0.137671", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMPZF", "relevance_score": "0.069094", "ticker_sentiment_score": "0.280935", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DCT", "relevance_score": "0.137671", "ticker_sentiment_score": "0.31038", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GLUE", "relevance_score": "0.205225", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DWAC", "relevance_score": "0.137671", "ticker_sentiment_score": "0.367879", "ticker_sentiment_label": "Bullish"}, {"ticker": "WBA", "relevance_score": "0.137671", "ticker_sentiment_score": "0.213433", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AVTE", "relevance_score": "0.137671", "ticker_sentiment_score": "0.32842", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CPTN", "relevance_score": "0.137671", "ticker_sentiment_score": "0.32842", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ACMR", "relevance_score": "0.137671", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.137671", "ticker_sentiment_score": "0.186651", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "MONTE ROSA CMN STK  ( GLUE )  - Monte Rosa Shares Rise As FDA Announced Clearance To MYC-Driven Cancer Study", "url": "https://www.benzinga.com/general/biotech/22/09/28760545/monte-rosa-shares-rise-as-fda-announced-clearance-to-myc-driven-cancer-study", "time_published": "20220906T152721", "authors": ["Ragothaman Srinivasan"], "summary": "The U.S. Food and Drug Administration ( FDA ) has announced clearance to Monte Rosa Therapeutics' GLUE investigational new drug application ( IND ) for its drug candidate MRT-2359 in patients with MYC-driven solid tumors.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/09/06/bz-pharma_4.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.048376, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.44622", "ticker_sentiment_score": "0.14379", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article", "time_published": "20220613T161842", "authors": ["Benzinga Insights"], "summary": "During Monday's trading, 1214 companies set new 52-week lows. The largest company by market cap to set a new 52-week low was Microsoft MSFT. Quoin Pharmaceuticals QNRX was the smallest company by market cap to set a new 52-week low. DexCom DXCM's stock fell the most, as it traded down 76.5% to ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_10371.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.018781, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CNTG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027909", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.009789", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWST", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000109", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.394081", "ticker_sentiment_label": "Bearish"}, {"ticker": "EXAS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006089", "ticker_sentiment_label": "Neutral"}, {"ticker": "DFH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002333", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTGN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005659", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006147", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008999", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.04494", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027053", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLW", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004474", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017209", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTAIF", "relevance_score": "0.002683", "ticker_sentiment_score": "0.004451", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.037999", "ticker_sentiment_label": "Neutral"}, {"ticker": "COUP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009823", "ticker_sentiment_label": "Neutral"}, {"ticker": "FARO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002432", "ticker_sentiment_label": "Neutral"}, {"ticker": "INBX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.019024", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTWO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.314549", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VIRT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.229754", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BOXL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.030487", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002018", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00374", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMED", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005022", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFBK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007708", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.016249", "ticker_sentiment_label": "Neutral"}, {"ticker": "GROM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005408", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUBE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001207", "ticker_sentiment_label": "Neutral"}, {"ticker": "AL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001131", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMAR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008257", "ticker_sentiment_label": "Neutral"}, {"ticker": "AP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004327", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008806", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000907", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.342178", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SSNC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004169", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSEC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006633", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.02233", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEGH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006247", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTCW", "relevance_score": "0.002683", "ticker_sentiment_score": "0.0055", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001487", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011287", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001164", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLOK", "relevance_score": "0.005366", "ticker_sentiment_score": "7.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009324", "ticker_sentiment_label": "Neutral"}, {"ticker": "SES", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.021897", "ticker_sentiment_label": "Neutral"}, {"ticker": "VITL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000388", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003981", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.041898", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008576", "ticker_sentiment_label": "Neutral"}, {"ticker": "F", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010108", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRR", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.003565", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTOO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004917", "ticker_sentiment_label": "Neutral"}, {"ticker": "BK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00219", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002581", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARCE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001268", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAVM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.037181", "ticker_sentiment_label": "Neutral"}, {"ticker": "THC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001967", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.039444", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000453", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWBC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002907", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACEL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009212", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZTS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005325", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.006309", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004249", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACB", "relevance_score": "0.005366", "ticker_sentiment_score": "-9e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.177272", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HQI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.028836", "ticker_sentiment_label": "Neutral"}, {"ticker": "BXMT", "relevance_score": "0.005366", "ticker_sentiment_score": "3.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001269", "ticker_sentiment_label": "Neutral"}, {"ticker": "JZXN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017992", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFGP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002325", "ticker_sentiment_label": "Neutral"}, {"ticker": "UGRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007002", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005908", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFSL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010451", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBAR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00184", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.197234", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ACR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.107514", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005633", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFIN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006145", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-9.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGMK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002013", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALXO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001482", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBNY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013582", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOUG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005157", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00131", "ticker_sentiment_label": "Neutral"}, {"ticker": "MINM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003307", "ticker_sentiment_label": "Neutral"}, {"ticker": "DD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000957", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002541", "ticker_sentiment_label": "Neutral"}, {"ticker": "REV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014392", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNCE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001189", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011785", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.023485", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.017301", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZOO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00021", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.47679", "ticker_sentiment_label": "Bearish"}, {"ticker": "GPS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006787", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.016373", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITW", "relevance_score": "0.005366", "ticker_sentiment_score": "0.015548", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZUL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.018071", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.03994", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007245", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYMT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007944", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005756", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENSC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.174993", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INFY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010375", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARDX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004067", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002323", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNDM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001063", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010741", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009463", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWMN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.015382", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDWR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.080194", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.0088", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001972", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009282", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.022412", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008283", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000178", "ticker_sentiment_label": "Neutral"}, {"ticker": "FPH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002374", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006113", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00144", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002664", "ticker_sentiment_label": "Neutral"}, {"ticker": "KZR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000298", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEAR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.371182", "ticker_sentiment_label": "Bearish"}, {"ticker": "SIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.014158", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.019862", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOYU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013209", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPRO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.104865", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007895", "ticker_sentiment_label": "Neutral"}, {"ticker": "FN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000843", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNB", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.008789", "ticker_sentiment_label": "Neutral"}, {"ticker": "STWD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002531", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.006072", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNGX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.049879", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.038976", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.0102", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.044669", "ticker_sentiment_label": "Neutral"}, {"ticker": "CION", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.0047", "ticker_sentiment_label": "Neutral"}, {"ticker": "GE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.346341", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CCCC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001494", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000903", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003168", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBLU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005037", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003672", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.242942", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SSSS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000192", "ticker_sentiment_label": "Neutral"}, {"ticker": "APDN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008319", "ticker_sentiment_label": "Neutral"}, {"ticker": "GP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004607", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLZE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004558", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.005083", "ticker_sentiment_label": "Neutral"}, {"ticker": "WULF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013405", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003042", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSTK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.013694", "ticker_sentiment_label": "Neutral"}, {"ticker": "VBIV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002076", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003243", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.050455", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000857", "ticker_sentiment_label": "Neutral"}, {"ticker": "HA", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.003169", "ticker_sentiment_label": "Neutral"}, {"ticker": "RICK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003331", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEAK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008186", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVCM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012919", "ticker_sentiment_label": "Neutral"}, {"ticker": "UMBF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.033109", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENTG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003676", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIII", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009225", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007906", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00294", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003236", "ticker_sentiment_label": "Neutral"}, {"ticker": "CABA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.073546", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00055", "ticker_sentiment_label": "Neutral"}, {"ticker": "OXLC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003855", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNRX", "relevance_score": "0.010731", "ticker_sentiment_score": "0.056798", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOUR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014221", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006197", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.212204", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UPH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001906", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGHT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007331", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.014763", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003835", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013876", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001742", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCBO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002769", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTGR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013135", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000152", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003007", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006871", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSKEF", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.001137", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011391", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002906", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMGN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00204", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003766", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGAL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.019917", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.002683", "ticker_sentiment_score": "0.0045", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002285", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDUP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007485", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002977", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.030157", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01473", "ticker_sentiment_label": "Neutral"}, {"ticker": "OEG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003312", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZIMV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001842", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTOL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006181", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005648", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOND", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013855", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005093", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.041687", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01318", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERJ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.0094", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBGI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006823", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOOD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001436", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVER", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00203", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRCT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00895", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.018778", "ticker_sentiment_score": "0.001179", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMAT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008479", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBIG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004566", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003902", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008305", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009111", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.010138", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00371", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004256", "ticker_sentiment_label": "Neutral"}, {"ticker": "URI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002609", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASML", "relevance_score": "0.005366", "ticker_sentiment_score": "0.0051", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTCT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000932", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003728", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017667", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002149", "ticker_sentiment_label": "Neutral"}, {"ticker": "KB", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.010525", "ticker_sentiment_label": "Neutral"}, {"ticker": "GWH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006451", "ticker_sentiment_label": "Neutral"}, {"ticker": "COF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000213", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBCI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005604", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008957", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBIO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005515", "ticker_sentiment_label": "Neutral"}, {"ticker": "SATL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006127", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUAD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.038077", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCFC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002964", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFRI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00759", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005261", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000143", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBTYA", "relevance_score": "0.002683", "ticker_sentiment_score": "0.001132", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOSS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01457", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMBIL", "relevance_score": "0.002683", "ticker_sentiment_score": "0.008572", "ticker_sentiment_label": "Neutral"}, {"ticker": "XYL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.055113", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001097", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001493", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006709", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01114", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.016704", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004563", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTMD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007197", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00283", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01399", "ticker_sentiment_label": "Neutral"}, {"ticker": "LE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.298506", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NEO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00126", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000582", "ticker_sentiment_label": "Neutral"}, {"ticker": "NET", "relevance_score": "0.005366", "ticker_sentiment_score": "0.034025", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014023", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBTX", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.172639", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005746", "ticker_sentiment_label": "Neutral"}, {"ticker": "LL", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.04368", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAW", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004566", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007224", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012256", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRAA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005135", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001664", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABNB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.020627", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPER", "relevance_score": "0.005366", "ticker_sentiment_score": "0.013746", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013786", "ticker_sentiment_label": "Neutral"}, {"ticker": "NHTC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.026834", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006603", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002043", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013974", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRGV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.030374", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.057433", "ticker_sentiment_label": "Neutral"}, {"ticker": "AME", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001235", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOPS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010887", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005912", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.021861", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACON", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005292", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002632", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROVR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00612", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001002", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHCR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.276654", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UNIT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005813", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.035506", "ticker_sentiment_label": "Neutral"}, {"ticker": "YELL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.024766", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALBO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002894", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.011699", "ticker_sentiment_label": "Neutral"}, {"ticker": "MU", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011682", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORCL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007027", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRUE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010378", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMTX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001984", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVNO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007961", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.022522", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003053", "ticker_sentiment_label": "Neutral"}, {"ticker": "LESL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003861", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002341", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001654", "ticker_sentiment_label": "Neutral"}, {"ticker": "CENX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004993", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010093", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMRE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003212", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.003976", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017414", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001716", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.28098", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MGTX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008235", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.024331", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRLD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.250534", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AMCX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008317", "ticker_sentiment_label": "Neutral"}, {"ticker": "NN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.051327", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001001", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004653", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSEC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00902", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.015", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.136277", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPE", "relevance_score": "0.005366", "ticker_sentiment_score": "4e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.04472", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000672", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.006213", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009636", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000725", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTGX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009216", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLXP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006137", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000996", "ticker_sentiment_label": "Neutral"}, {"ticker": "OB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017906", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOUN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002249", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPR", "relevance_score": "0.008048", "ticker_sentiment_score": "0.001455", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCLH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003319", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.282133", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LBPS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005701", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTIS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002654", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.253696", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VLDR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.031864", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009077", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.005366", "ticker_sentiment_score": "0.010008", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRMK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007329", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002994", "ticker_sentiment_label": "Neutral"}, {"ticker": "PH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000858", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADTX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000173", "ticker_sentiment_label": "Neutral"}, {"ticker": "PK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.026715", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTRH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000458", "ticker_sentiment_label": "Neutral"}, {"ticker": "RUBY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00549", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTDR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.289087", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FXLV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000102", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNON", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.024476", "ticker_sentiment_label": "Neutral"}, {"ticker": "APO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005626", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIAV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000652", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLWS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005501", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.034935", "ticker_sentiment_label": "Neutral"}, {"ticker": "XSPA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003054", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.029459", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003869", "ticker_sentiment_label": "Neutral"}, {"ticker": "STM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.26252", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GSBD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005083", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000877", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLBD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.030902", "ticker_sentiment_label": "Neutral"}, {"ticker": "RRR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00391", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012266", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUK", "relevance_score": "0.002683", "ticker_sentiment_score": "0.029025", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZENV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003257", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003011", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003282", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005966", "ticker_sentiment_label": "Neutral"}, {"ticker": "QS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003825", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLAB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.065602", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006692", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGNY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.033419", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUNE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027877", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABSI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008994", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.013387", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004451", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORGO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002621", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000994", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005841", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRDS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007866", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLYM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.17614", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SNTI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008436", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWOD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001806", "ticker_sentiment_label": "Neutral"}, {"ticker": "IAS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000191", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007939", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRSK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001025", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTFT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00147", "ticker_sentiment_label": "Neutral"}, {"ticker": "KEY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006956", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLBX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.044451", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002691", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014395", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTTR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.05491", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.035328", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.014448", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000107", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLYW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.280495", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TXN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004765", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002255", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00155", "ticker_sentiment_label": "Neutral"}, {"ticker": "FITB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00525", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006384", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACVA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.167193", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.023907", "ticker_sentiment_label": "Neutral"}, {"ticker": "SG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.101005", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREQ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.426684", "ticker_sentiment_label": "Bearish"}, {"ticker": "NLY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.018267", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002427", "ticker_sentiment_label": "Neutral"}, {"ticker": "KFY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003166", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKNO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.013786", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002735", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.050893", "ticker_sentiment_label": "Neutral"}, {"ticker": "PPBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002399", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000644", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFET", "relevance_score": "0.005366", "ticker_sentiment_score": "0.0403", "ticker_sentiment_label": "Neutral"}, {"ticker": "SY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01828", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000404", "ticker_sentiment_label": "Neutral"}, {"ticker": "SILC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003704", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000847", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004694", "ticker_sentiment_label": "Neutral"}, {"ticker": "LII", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003456", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPEN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005675", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATXS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006552", "ticker_sentiment_label": "Neutral"}, {"ticker": "VATE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004868", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZNP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001317", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.03375", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.015914", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPMC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013229", "ticker_sentiment_label": "Neutral"}, {"ticker": "DESP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003244", "ticker_sentiment_label": "Neutral"}, {"ticker": "VORB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011817", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01245", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMWB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009317", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYNH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.015156", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00235", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMKR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002277", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCRD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017984", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008789", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.046567", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008791", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.028722", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007241", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRON", "relevance_score": "0.005366", "ticker_sentiment_score": "0.023575", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.040438", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00893", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMFC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.02795", "ticker_sentiment_label": "Neutral"}, {"ticker": "UP", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.017094", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005889", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLDX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003648", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTLO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003256", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTRS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.015322", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003469", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005381", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003888", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002958", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007964", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000464", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNHI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014746", "ticker_sentiment_label": "Neutral"}, {"ticker": "KORE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.017331", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000409", "ticker_sentiment_label": "Neutral"}, {"ticker": "INVH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006232", "ticker_sentiment_label": "Neutral"}, {"ticker": "NDSN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014258", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.021784", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007028", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBDC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007026", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYNA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004191", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVTC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001847", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01029", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBLA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004869", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLEU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008775", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001806", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00297", "ticker_sentiment_label": "Neutral"}, {"ticker": "UHID", "relevance_score": "0.002683", "ticker_sentiment_score": "0.006598", "ticker_sentiment_label": "Neutral"}, {"ticker": "POET", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000856", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWIN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.09399", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003517", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMBK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009154", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000764", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARWR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000431", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00341", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006057", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005028", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.036964", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011918", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIFE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.106035", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVNC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01838", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIPO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.018148", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDXG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006823", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006081", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLYB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000186", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004032", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYN", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.004229", "ticker_sentiment_label": "Neutral"}, {"ticker": "STER", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.037725", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUMU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01307", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014019", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004274", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.002683", "ticker_sentiment_score": "0.035061", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLIN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.410902", "ticker_sentiment_label": "Bearish"}, {"ticker": "BZH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011111", "ticker_sentiment_label": "Neutral"}, {"ticker": "OST", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003768", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007762", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002945", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005683", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRHC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.016485", "ticker_sentiment_label": "Neutral"}, {"ticker": "EQIX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000866", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKFG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008322", "ticker_sentiment_label": "Neutral"}, {"ticker": "REKR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014413", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001112", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.047866", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.010639", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZFD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011203", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004841", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRMW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000353", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWKS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.022588", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBWI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.060782", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.177137", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KLR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006762", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.034866", "ticker_sentiment_score": "0.006675", "ticker_sentiment_label": "Neutral"}, {"ticker": "FERG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.214254", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MPW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000688", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLED", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009965", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVPH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.016238", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBTX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.043124", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETZ", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003573", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.032893", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000512", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006642", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001026", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMER", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017825", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSBK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.064589", "ticker_sentiment_label": "Neutral"}, {"ticker": "TY-P", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.006567", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.010323", "ticker_sentiment_label": "Neutral"}, {"ticker": "CONN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.079529", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003508", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.092696", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.030029", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHPW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.031876", "ticker_sentiment_label": "Neutral"}, {"ticker": "HHC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.012851", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUMA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.292681", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FRME", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002489", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYCC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006409", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00436", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGTI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009179", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOMO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010966", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAZR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002149", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESRT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003209", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006306", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01173", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBNC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.038416", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRUS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003047", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANSS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007534", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNAZ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000638", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYRA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027316", "ticker_sentiment_label": "Neutral"}, {"ticker": "NATR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.016507", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCMG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00216", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAZY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00426", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBGI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003944", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPCB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003166", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNMD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00816", "ticker_sentiment_label": "Neutral"}, {"ticker": "SITE", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.147209", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBP", "relevance_score": "0.002683", "ticker_sentiment_score": "5.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SITC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.285853", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DBRG-P-I", "relevance_score": "0.002683", "ticker_sentiment_score": "0.011535", "ticker_sentiment_label": "Neutral"}, {"ticker": "PDSB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005046", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005913", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000958", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.020239", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFNC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.022321", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00424", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPRT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003463", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003073", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005686", "ticker_sentiment_label": "Neutral"}, {"ticker": "JYNT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.058627", "ticker_sentiment_label": "Neutral"}, {"ticker": "MXCT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009997", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCHW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004248", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.020459", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002649", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAVI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000292", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHRT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001094", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVBF", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001092", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007576", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001048", "ticker_sentiment_label": "Neutral"}, {"ticker": "VFF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009866", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLNK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.457779", "ticker_sentiment_label": "Bearish"}, {"ticker": "VSAT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001534", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011298", "ticker_sentiment_label": "Neutral"}, {"ticker": "THRY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007243", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001505", "ticker_sentiment_label": "Neutral"}, {"ticker": "THRX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001096", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.217102", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BLND", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006675", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENIA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001103", "ticker_sentiment_label": "Neutral"}, {"ticker": "GIB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000218", "ticker_sentiment_label": "Neutral"}, {"ticker": "DATS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000151", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001912", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITIC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00203", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORZ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.015091", "ticker_sentiment_label": "Neutral"}, {"ticker": "GIL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009558", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.012286", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEAV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007896", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLLS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007774", "ticker_sentiment_label": "Neutral"}, {"ticker": "EQOS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012653", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.076716", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFWM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004455", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011165", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPTN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001029", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELEV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006705", "ticker_sentiment_label": "Neutral"}, {"ticker": "TACT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.287375", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TREE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006545", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006116", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGRY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011411", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASAN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011856", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001405", "ticker_sentiment_label": "Neutral"}, {"ticker": "OZK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000702", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMDA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01837", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000777", "ticker_sentiment_label": "Neutral"}, {"ticker": "PARA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007437", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.022206", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNTV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.185813", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006554", "ticker_sentiment_label": "Neutral"}, {"ticker": "INM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014567", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGFV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.033718", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.021183", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTCH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.072571", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRNQ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005018", "ticker_sentiment_label": "Neutral"}, {"ticker": "JELD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.245399", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VKTX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.033916", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGIO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.019831", "ticker_sentiment_label": "Neutral"}, {"ticker": "LJPC", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.048285", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.033555", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLAY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005318", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIGI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000392", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMRN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001003", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001128", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTEX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006763", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVAX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006605", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.062872", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.002683", "ticker_sentiment_score": "0.047017", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001794", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.040702", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000426", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.310839", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NYT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027556", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.254871", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CCK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003342", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRMN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003882", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDAY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.034094", "ticker_sentiment_label": "Neutral"}, {"ticker": "AINV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008496", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002725", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.531702", "ticker_sentiment_label": "Bearish"}, {"ticker": "KTB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004746", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012133", "ticker_sentiment_label": "Neutral"}, {"ticker": "USFD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005066", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRNA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007569", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAIN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00738", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:GBP", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.037725", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Thursday", "url": "https://www.benzinga.com/markets/options/22/05/27422270/52-weeks-high-and-low-article", "time_published": "20220526T161527", "authors": ["Benzinga Insights"], "summary": "On Thursday, 94 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Medtronic ( NYSE:MDT ) was the biggest company on a market cap basis to set a new 52-week low. Performance Shipping ( NASDAQ:PSHG ) was the smallest company when considering market cap to set a new 52-w", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_9380.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.011819, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CNTG", "relevance_score": "0.072913", "ticker_sentiment_score": "0.000525", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHI", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.001475", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.024334", "ticker_sentiment_score": "-0.000986", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNCE", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000479", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKYI", "relevance_score": "0.048646", "ticker_sentiment_score": "0.015604", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRA", "relevance_score": "0.048646", "ticker_sentiment_score": "0.001343", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDB", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.018766", "ticker_sentiment_label": "Neutral"}, {"ticker": "SISI", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.00196", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIVE", "relevance_score": "0.048646", "ticker_sentiment_score": "0.008847", "ticker_sentiment_label": "Neutral"}, {"ticker": "XELA", "relevance_score": "0.048646", "ticker_sentiment_score": "0.004728", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERI", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.001793", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAS", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.278085", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GLUE", "relevance_score": "0.048646", "ticker_sentiment_score": "0.0087", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.024334", "ticker_sentiment_score": "-0.010991", "ticker_sentiment_label": "Neutral"}, {"ticker": "SECO", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000229", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYDEV", "relevance_score": "0.048646", "ticker_sentiment_score": "0.000178", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBI", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.00796", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.165177", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MDT", "relevance_score": "0.097111", "ticker_sentiment_score": "0.057725", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCCI", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.003766", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTHR", "relevance_score": "0.048646", "ticker_sentiment_score": "0.026773", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.026404", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.048646", "ticker_sentiment_score": "0.011329", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALBO", "relevance_score": "0.048646", "ticker_sentiment_score": "0.033583", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCFY", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.005106", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.011382", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.048646", "ticker_sentiment_score": "0.008038", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.263816", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AUTO", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.006287", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAIN", "relevance_score": "0.048646", "ticker_sentiment_score": "0.001458", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRCA", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.328832", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AYLA", "relevance_score": "0.048646", "ticker_sentiment_score": "0.04831", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRXT", "relevance_score": "0.048646", "ticker_sentiment_score": "0.010365", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.002322", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTTA", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.013279", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.048646", "ticker_sentiment_score": "0.015792", "ticker_sentiment_label": "Neutral"}, {"ticker": "INVO", "relevance_score": "0.048646", "ticker_sentiment_score": "0.004355", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.0124", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000809", "ticker_sentiment_label": "Neutral"}, {"ticker": "NN", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.045491", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.048646", "ticker_sentiment_score": "0.008556", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.048646", "ticker_sentiment_score": "0.00015", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERI", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000371", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLAR", "relevance_score": "0.024334", "ticker_sentiment_score": "0.010365", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDOG", "relevance_score": "0.048646", "ticker_sentiment_score": "0.010999", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRR", "relevance_score": "0.048646", "ticker_sentiment_score": "4.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMCO", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.304069", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CYCC", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.001231", "ticker_sentiment_label": "Neutral"}, {"ticker": "YRD", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.001611", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUSN", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.003561", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLL", "relevance_score": "0.048646", "ticker_sentiment_score": "0.005648", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALOT", "relevance_score": "0.048646", "ticker_sentiment_score": "0.034797", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTCH", "relevance_score": "0.048646", "ticker_sentiment_score": "0.056144", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUL", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.01067", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.048646", "ticker_sentiment_score": "0.031609", "ticker_sentiment_label": "Neutral"}, {"ticker": "UHAL", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.003901", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.009053", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKNO", "relevance_score": "0.048646", "ticker_sentiment_score": "0.003493", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARA", "relevance_score": "0.048646", "ticker_sentiment_score": "0.00472", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVDL", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.017898", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.00163", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.352546", "ticker_sentiment_label": "Bearish"}, {"ticker": "CRNX", "relevance_score": "0.048646", "ticker_sentiment_score": "0.007099", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUT", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.035012", "ticker_sentiment_label": "Neutral"}, {"ticker": "OVID", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.007563", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSHG", "relevance_score": "0.097111", "ticker_sentiment_score": "0.097808", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALA", "relevance_score": "0.048646", "ticker_sentiment_score": "0.063248", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHC", "relevance_score": "0.048646", "ticker_sentiment_score": "0.001411", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNGY", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.005391", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKU", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.006577", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCTL", "relevance_score": "0.048646", "ticker_sentiment_score": "0.002033", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.048646", "ticker_sentiment_score": "0.004891", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOT", "relevance_score": "0.048646", "ticker_sentiment_score": "0.000275", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBAC", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000741", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZUO", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000585", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAVA", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000186", "ticker_sentiment_label": "Neutral"}, {"ticker": "MANU", "relevance_score": "0.048646", "ticker_sentiment_score": "0.044162", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.048646", "ticker_sentiment_score": "0.000438", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.048646", "ticker_sentiment_score": "0.008555", "ticker_sentiment_label": "Neutral"}, {"ticker": "JACK", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.005257", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNON", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.078959", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Wednesday", "url": "https://www.benzinga.com/markets/options/22/05/27141482/52-weeks-high-and-low-article", "time_published": "20220511T162815", "authors": ["Benzinga Insights"], "summary": "On Wednesday, 807 companies reached new 52-week lows.\nThings to Consider About Today's 52-Week Lows:\nAmazon.com  ( NASDAQ:AMZN )  was the largest company by market cap to set a new 52-week low.\nGames & Esports  ( NASDAQ:GEEXW )  was the smallest company by market cap to set a new 52-week low.\nView  ", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_8443.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.026939, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "FLGC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010843", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00124", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICLR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.036124", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.003453", "ticker_sentiment_score": "0.006292", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEDS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003313", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000149", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002042", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005129", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROIV", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000991", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVID", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005953", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004023", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTAIF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.012576", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMRD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002667", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCRT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.370079", "ticker_sentiment_label": "Bearish"}, {"ticker": "SCOR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01049", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMWL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.053563", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007315", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008312", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004985", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.006905", "ticker_sentiment_score": "0.046669", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006647", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMED", "relevance_score": "0.006905", "ticker_sentiment_score": "0.028036", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOTV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.0346", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.006905", "ticker_sentiment_score": "8.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001386", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.435265", "ticker_sentiment_label": "Bearish"}, {"ticker": "AZRE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007661", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBOT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010696", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEHL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000104", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001099", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.569147", "ticker_sentiment_label": "Bearish"}, {"ticker": "VITL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.01899", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009834", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTOO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002672", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXON", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006481", "ticker_sentiment_label": "Neutral"}, {"ticker": "INDI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.023031", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYND", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006225", "ticker_sentiment_label": "Neutral"}, {"ticker": "HROW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00396", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004993", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000956", "ticker_sentiment_label": "Neutral"}, {"ticker": "W", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017889", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRBY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.030942", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006892", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006208", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.027974", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTER", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001811", "ticker_sentiment_label": "Neutral"}, {"ticker": "JZXN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004785", "ticker_sentiment_label": "Neutral"}, {"ticker": "UGRO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003781", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000185", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001624", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.033286", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.032128", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007747", "ticker_sentiment_label": "Neutral"}, {"ticker": "REE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000545", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFIN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014035", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.026043", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARCT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002584", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOUG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.030553", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005663", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.102966", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATIP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.018006", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010726", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUEN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.083313", "ticker_sentiment_label": "Neutral"}, {"ticker": "DH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002316", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNCE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01368", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKTW", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001209", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.114162", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001387", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002708", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.041261", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000686", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000674", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001014", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.006905", "ticker_sentiment_score": "-5.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029453", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.503669", "ticker_sentiment_label": "Bearish"}, {"ticker": "ABEO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010621", "ticker_sentiment_label": "Neutral"}, {"ticker": "RFL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001583", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARDS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.044931", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.057114", "ticker_sentiment_label": "Neutral"}, {"ticker": "TJX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.025648", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLPN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.442405", "ticker_sentiment_label": "Bearish"}, {"ticker": "LEJU", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002269", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007044", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDRA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013268", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNGX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.027942", "ticker_sentiment_label": "Neutral"}, {"ticker": "VXRT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00338", "ticker_sentiment_label": "Neutral"}, {"ticker": "YUM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.028553", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLDB", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010371", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFMD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002608", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONTF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.033985", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00821", "ticker_sentiment_label": "Neutral"}, {"ticker": "AADI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008683", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001147", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.029975", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.003453", "ticker_sentiment_score": "0.00083", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001639", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.031721", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006969", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010744", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005509", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRWG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007522", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003138", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIDE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007695", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCCC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002347", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.026602", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006817", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000946", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003622", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLTX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001759", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSSS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002882", "ticker_sentiment_label": "Neutral"}, {"ticker": "APDN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.01973", "ticker_sentiment_label": "Neutral"}, {"ticker": "GP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001488", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009899", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELOX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007027", "ticker_sentiment_label": "Neutral"}, {"ticker": "WULF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004752", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCID", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001298", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002991", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.015008", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006371", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOLO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000529", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVCM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002414", "ticker_sentiment_label": "Neutral"}, {"ticker": "HD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004448", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003716", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005806", "ticker_sentiment_label": "Neutral"}, {"ticker": "APEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006652", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSWA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.032353", "ticker_sentiment_label": "Neutral"}, {"ticker": "APEI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.274715", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VERI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009191", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.006905", "ticker_sentiment_score": "-7.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NABL", "relevance_score": "0.01381", "ticker_sentiment_score": "-0.065212", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHAK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.016476", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009625", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.035094", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.017236", "ticker_sentiment_label": "Neutral"}, {"ticker": "IO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004472", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPAA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004494", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWFL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005494", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMGN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006302", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.027744", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019477", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006897", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDUP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.380308", "ticker_sentiment_label": "Bearish"}, {"ticker": "YTEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003037", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.020472", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMGO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.03797", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.199176", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SBTX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008026", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHPT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00697", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.284624", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SMP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.027647", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.033445", "ticker_sentiment_label": "Neutral"}, {"ticker": "DYNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004023", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFRM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010277", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPZM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009908", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRCT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000558", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.020713", "ticker_sentiment_score": "-0.00707", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014329", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001403", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSPN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004038", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029958", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.053345", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.395079", "ticker_sentiment_label": "Bearish"}, {"ticker": "IONQ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000885", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZCRF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.01049", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.057804", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFMS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002302", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.057018", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACMR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013737", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASMB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002159", "ticker_sentiment_label": "Neutral"}, {"ticker": "KD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000517", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKIL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00385", "ticker_sentiment_label": "Neutral"}, {"ticker": "CEMI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004625", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAMOD", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.011888", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.201653", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PLRX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014804", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBTYA", "relevance_score": "0.01381", "ticker_sentiment_score": "0.000537", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.034535", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002931", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009368", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00339", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014879", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00256", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005779", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVNA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02828", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNRC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008229", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDXX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009155", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.04243", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTRA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.358226", "ticker_sentiment_label": "Bearish"}, {"ticker": "TARA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00569", "ticker_sentiment_label": "Neutral"}, {"ticker": "LL", "relevance_score": "0.003453", "ticker_sentiment_score": "0.006707", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCW", "relevance_score": "0.006905", "ticker_sentiment_score": "0.03686", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.360118", "ticker_sentiment_label": "Bearish"}, {"ticker": "LAW", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00929", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAZ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003194", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.023385", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELVT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000891", "ticker_sentiment_label": "Neutral"}, {"ticker": "MODN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.020967", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014444", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABNB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004281", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002269", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCH", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000342", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCSA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00821", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000891", "ticker_sentiment_label": "Neutral"}, {"ticker": "MC", "relevance_score": "0.006905", "ticker_sentiment_score": "-3.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.003453", "ticker_sentiment_score": "0.131467", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLNE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005482", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOTH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029909", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.020147", "ticker_sentiment_label": "Neutral"}, {"ticker": "ML", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005557", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGC-U", "relevance_score": "0.003453", "ticker_sentiment_score": "0.008905", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHCR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.016002", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.392024", "ticker_sentiment_label": "Bearish"}, {"ticker": "SMMT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010153", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAST", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002248", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLUG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011101", "ticker_sentiment_label": "Neutral"}, {"ticker": "LESL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000751", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019578", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNWD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.015302", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.01087", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003034", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004071", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIXT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007657", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGRN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006713", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKLZ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.018388", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003455", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004429", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCTR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.066657", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009858", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.001463", "ticker_sentiment_label": "Neutral"}, {"ticker": "INPX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003723", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.012664", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.219042", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AEVA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009159", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLXP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.011478", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNDY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.031329", "ticker_sentiment_label": "Neutral"}, {"ticker": "OB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001471", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTVT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00428", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003443", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001551", "ticker_sentiment_label": "Neutral"}, {"ticker": "OM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007828", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.03401", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMFA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.021611", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNUS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.033908", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02022", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIHO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005958", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004778", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRPX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.042368", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006722", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006844", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003882", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMAT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005504", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.003453", "ticker_sentiment_score": "0.003362", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUVI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.019138", "ticker_sentiment_label": "Neutral"}, {"ticker": "API", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003362", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCEL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012249", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNFT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007461", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTOS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004453", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTRS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001344", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001857", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARQQ", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007561", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012451", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00277", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.006905", "ticker_sentiment_score": "4.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013924", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01167", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004193", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000195", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTIX", "relevance_score": "0.006905", "ticker_sentiment_score": "5.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFOI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029837", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009979", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004065", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNXT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013037", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008058", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEAT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010594", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARRY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.020369", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02254", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSFE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014456", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.066369", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017007", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOVNP", "relevance_score": "0.003453", "ticker_sentiment_score": "0.006269", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAND", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.031576", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNGO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02275", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEYE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001988", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012576", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002829", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRDS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.354538", "ticker_sentiment_label": "Bearish"}, {"ticker": "NCMI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00193", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.259224", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MIR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004637", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOST", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.074059", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004011", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDRO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.024874", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOPN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001667", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRAY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.015082", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.012462", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005954", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLAR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003477", "ticker_sentiment_label": "Neutral"}, {"ticker": "COGT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007373", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIMS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001572", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADXN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009111", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMCO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005184", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00475", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.020635", "ticker_sentiment_label": "Neutral"}, {"ticker": "SE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000674", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACVA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002797", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.010357", "ticker_sentiment_score": "0.001464", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCRX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008988", "ticker_sentiment_label": "Neutral"}, {"ticker": "DYN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010556", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLBT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000724", "ticker_sentiment_label": "Neutral"}, {"ticker": "KGC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.012165", "ticker_sentiment_label": "Neutral"}, {"ticker": "QSI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004396", "ticker_sentiment_label": "Neutral"}, {"ticker": "SY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004931", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001103", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNFR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019067", "ticker_sentiment_label": "Neutral"}, {"ticker": "HILS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001252", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARTW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000834", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003095", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003971", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001533", "ticker_sentiment_label": "Neutral"}, {"ticker": "NNDM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002124", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.326686", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RIOT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02771", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOLF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.083853", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSTR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003562", "ticker_sentiment_label": "Neutral"}, {"ticker": "VORB", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00343", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOOP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005015", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALIT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.031917", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPWK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.041747", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEPG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007504", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEV", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007498", "ticker_sentiment_label": "Neutral"}, {"ticker": "UA", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.029087", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011377", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.298818", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PZZA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010066", "ticker_sentiment_label": "Neutral"}, {"ticker": "FENG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001777", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFFP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009522", "ticker_sentiment_label": "Neutral"}, {"ticker": "UP", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.004382", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCYT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00325", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSPR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.0191", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001282", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWIM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004749", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001507", "ticker_sentiment_label": "Neutral"}, {"ticker": "LASR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008075", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009289", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.392113", "ticker_sentiment_label": "Bearish"}, {"ticker": "FBIO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002737", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.025009", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWUP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.028695", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVTL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.016997", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSHD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.039738", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011907", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPAY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009098", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHOP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005061", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001674", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNSA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002578", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000342", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITSF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.021993", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYEL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000797", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTPI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007203", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPTH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.362989", "ticker_sentiment_label": "Bearish"}, {"ticker": "NCTY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006714", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007314", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010066", "ticker_sentiment_label": "Neutral"}, {"ticker": "WW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014569", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010513", "ticker_sentiment_label": "Neutral"}, {"ticker": "OUST", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.294166", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ORMP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000939", "ticker_sentiment_label": "Neutral"}, {"ticker": "KZIA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007505", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRSN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.374918", "ticker_sentiment_label": "Bearish"}, {"ticker": "SFIX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000996", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIDR", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.001988", "ticker_sentiment_label": "Neutral"}, {"ticker": "STEP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.045373", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017264", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004172", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.001723", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLIN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008014", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTIM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.285345", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HYPR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003699", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUWE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001889", "ticker_sentiment_label": "Neutral"}, {"ticker": "OST", "relevance_score": "0.006905", "ticker_sentiment_score": "0.0003", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000912", "ticker_sentiment_label": "Neutral"}, {"ticker": "XL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.04092", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEWR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012623", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSUMF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSTGF", "relevance_score": "0.003453", "ticker_sentiment_score": "0.002248", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKFG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010603", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.021702", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02631", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001123", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006837", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNCH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001556", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.0152", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009431", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007666", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002913", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTRA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005884", "ticker_sentiment_label": "Neutral"}, {"ticker": "HITI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.059974", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETQ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004692", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007552", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVPH", "relevance_score": "0.006905", "ticker_sentiment_score": "3.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PALT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000267", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.30025", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TNYA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.021404", "ticker_sentiment_label": "Neutral"}, {"ticker": "RELY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011834", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007334", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005064", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCTH", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010679", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.280779", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FVRR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000429", "ticker_sentiment_label": "Neutral"}, {"ticker": "CONN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003156", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.332594", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ELAN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005139", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007599", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.040609", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYLPF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.303151", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EAR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.515459", "ticker_sentiment_label": "Bearish"}, {"ticker": "ZS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002065", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002864", "ticker_sentiment_label": "Neutral"}, {"ticker": "RRGB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004799", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLKB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003166", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.038783", "ticker_sentiment_label": "Neutral"}, {"ticker": "HHC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002274", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYCC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003547", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOMO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.032123", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009183", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00365", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003406", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.044645", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRZE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019028", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009685", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005539", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKKT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010394", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIDM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004099", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003036", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012244", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.033794", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017902", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019061", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004583", "ticker_sentiment_label": "Neutral"}, {"ticker": "MXCT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008606", "ticker_sentiment_label": "Neutral"}, {"ticker": "TELA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005144", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICHR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019517", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009332", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUNW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.015065", "ticker_sentiment_label": "Neutral"}, {"ticker": "URBN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.185111", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "APYX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00253", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003239", "ticker_sentiment_label": "Neutral"}, {"ticker": "POLA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004544", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLNK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.473604", "ticker_sentiment_label": "Bearish"}, {"ticker": "BRSYF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.009217", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.065524", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003907", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNSO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003669", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010652", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLND", "relevance_score": "0.006905", "ticker_sentiment_score": "0.016657", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUMO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005464", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004492", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006496", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMAB", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006537", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORZ", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005167", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRTS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002222", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012732", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009064", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYMR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009894", "ticker_sentiment_label": "Neutral"}, {"ticker": "SI-P-A", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.017179", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIBS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.025121", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAUT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001817", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEBR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019209", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIND", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.542631", "ticker_sentiment_label": "Bearish"}, {"ticker": "GOEV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006919", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLNK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006117", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.46795", "ticker_sentiment_label": "Bearish"}, {"ticker": "TACT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00013", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005671", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGPPF", "relevance_score": "0.003453", "ticker_sentiment_score": "0.001751", "ticker_sentiment_label": "Neutral"}, {"ticker": "GALT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.303128", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HLF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.030714", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01328", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009974", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.062454", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIMI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000832", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001263", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLBE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006434", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000746", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTCH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017918", "ticker_sentiment_label": "Neutral"}, {"ticker": "VHC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007314", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLAY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002596", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKLA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.086181", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003579", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWBR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005085", "ticker_sentiment_label": "Neutral"}, {"ticker": "HURC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007955", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.006905", "ticker_sentiment_score": "0.025491", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004826", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009901", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTAI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008017", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001828", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIDI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004273", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003009", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003203", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLNN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.079266", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCON", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007781", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.05939", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRSO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009408", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.002124", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NMR", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.326686", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRYPTO:AMPL", "relevance_score": "0.003453", "ticker_sentiment_score": "0.040609", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTX", "relevance_score": "0.003453", "ticker_sentiment_score": "0.00696", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:EOT", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.000625", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:SLS", "relevance_score": "0.003453", "ticker_sentiment_score": "0.009625", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:TRX", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.198959", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Monte Rosa Therapeutics Reports First Quarter 2022 Financial Results and Business Updates", "url": "https://www.globenewswire.com/news-release/2022/05/11/2440695/0/en/Monte-Rosa-Therapeutics-Reports-First-Quarter-2022-Financial-Results-and-Business-Updates.html", "time_published": "20220511T113000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "- Presented Preclinical Data at AACR Annual Meeting Supporting Clinical Development of MRT-2359 as Potent and Selective GSPT1-directed Molecular Glue Degrader in Solid Tumors; Company on Track to File Investigational New Drug  ( IND )  Application Mid-year -", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.011812, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.083589", "ticker_sentiment_score": "0.017702", "ticker_sentiment_label": "Neutral"}]}, {"title": "53 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/03/26365918/53-biggest-movers-from-yesterday", "time_published": "20220330T073305", "authors": [], "summary": "Gainers\nIGM Biosciences, Inc.  ( NASDAQ: IGMS )  shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA  ( NASDAQ: SNY )  and IGM Biosciences signed an exclusive worldwide collaboration agreement for IgM antibodies agonists against three oncology targets and three immunology/inflammation targ", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_422.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.980509"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.003276, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AVAH", "relevance_score": "0.068404", "ticker_sentiment_score": "-0.032402", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEDS", "relevance_score": "0.068404", "ticker_sentiment_score": "0.025142", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLAP", "relevance_score": "0.068404", "ticker_sentiment_score": "0.001637", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOHO", "relevance_score": "0.068404", "ticker_sentiment_score": "0.000669", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLS", "relevance_score": "0.102449", "ticker_sentiment_score": "0.000457", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAS", "relevance_score": "0.068404", "ticker_sentiment_score": "0.00167", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.068404", "ticker_sentiment_score": "0.001236", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRX", "relevance_score": "0.068404", "ticker_sentiment_score": "0.002474", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDYN", "relevance_score": "0.068404", "ticker_sentiment_score": "0.001509", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBU", "relevance_score": "0.034233", "ticker_sentiment_score": "0.010182", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.102449", "ticker_sentiment_score": "-0.003856", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNDB", "relevance_score": "0.102449", "ticker_sentiment_score": "0.001236", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.068404", "ticker_sentiment_score": "0.000961", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGI", "relevance_score": "0.068404", "ticker_sentiment_score": "0.001187", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRS", "relevance_score": "0.034233", "ticker_sentiment_score": "0.001626", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBLG", "relevance_score": "0.102449", "ticker_sentiment_score": "-0.011129", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.068404", "ticker_sentiment_score": "-0.155262", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TISI", "relevance_score": "0.068404", "ticker_sentiment_score": "0.001064", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELMS", "relevance_score": "0.068404", "ticker_sentiment_score": "0.002929", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRIN", "relevance_score": "0.068404", "ticker_sentiment_score": "-0.000391", "ticker_sentiment_label": "Neutral"}, {"ticker": "UXIN", "relevance_score": "0.068404", "ticker_sentiment_score": "-0.004404", "ticker_sentiment_label": "Neutral"}, {"ticker": "THMO", "relevance_score": "0.068404", "ticker_sentiment_score": "-0.014027", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.034233", "ticker_sentiment_score": "0.008161", "ticker_sentiment_label": "Neutral"}, {"ticker": "CONN", "relevance_score": "0.068404", "ticker_sentiment_score": "0.000613", "ticker_sentiment_label": "Neutral"}, {"ticker": "SXTC", "relevance_score": "0.068404", "ticker_sentiment_score": "0.012339", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNTA", "relevance_score": "0.068404", "ticker_sentiment_score": "0.008421", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNTE", "relevance_score": "0.102449", "ticker_sentiment_score": "-0.004261", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVIS", "relevance_score": "0.102449", "ticker_sentiment_score": "0.008854", "ticker_sentiment_label": "Neutral"}, {"ticker": "REVB", "relevance_score": "0.068404", "ticker_sentiment_score": "0.00135", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRSN", "relevance_score": "0.068404", "ticker_sentiment_score": "0.003387", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOOD", "relevance_score": "0.102449", "ticker_sentiment_score": "0.032564", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLSN", "relevance_score": "0.068404", "ticker_sentiment_score": "0.010182", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLBX", "relevance_score": "0.068404", "ticker_sentiment_score": "0.007555", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYMC", "relevance_score": "0.068404", "ticker_sentiment_score": "0.014507", "ticker_sentiment_label": "Neutral"}, {"ticker": "SVFD", "relevance_score": "0.068404", "ticker_sentiment_score": "0.001155", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIAN", "relevance_score": "0.068404", "ticker_sentiment_score": "0.001865", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCYX", "relevance_score": "0.068404", "ticker_sentiment_score": "0.000835", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUP", "relevance_score": "0.068404", "ticker_sentiment_score": "0.004979", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPCN", "relevance_score": "0.102449", "ticker_sentiment_score": "0.001626", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEXI", "relevance_score": "0.068404", "ticker_sentiment_score": "0.002014", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBUC", "relevance_score": "0.034233", "ticker_sentiment_score": "0.010182", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOVE", "relevance_score": "0.102449", "ticker_sentiment_score": "0.029608", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.068404", "ticker_sentiment_score": "0.002387", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEXPF", "relevance_score": "0.034233", "ticker_sentiment_score": "0.002014", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUUD", "relevance_score": "0.068404", "ticker_sentiment_score": "0.001406", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.068404", "ticker_sentiment_score": "0.005661", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFAI", "relevance_score": "0.068404", "ticker_sentiment_score": "0.008216", "ticker_sentiment_label": "Neutral"}, {"ticker": "IGMS", "relevance_score": "0.102449", "ticker_sentiment_score": "0.005661", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALA", "relevance_score": "0.068404", "ticker_sentiment_score": "0.00086", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELZ", "relevance_score": "0.068404", "ticker_sentiment_score": "0.004442", "ticker_sentiment_label": "Neutral"}, {"ticker": "KXIN", "relevance_score": "0.068404", "ticker_sentiment_score": "0.003824", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAVE", "relevance_score": "0.068404", "ticker_sentiment_score": "0.002706", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAX", "relevance_score": "0.068404", "ticker_sentiment_score": "-0.056521", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHIL", "relevance_score": "0.102449", "ticker_sentiment_score": "0.008161", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNA", "relevance_score": "0.068404", "ticker_sentiment_score": "0.015127", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLG", "relevance_score": "0.068404", "ticker_sentiment_score": "0.001835", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.068404", "ticker_sentiment_score": "0.02064", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVR", "relevance_score": "0.068404", "ticker_sentiment_score": "0.008424", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLNO", "relevance_score": "0.068404", "ticker_sentiment_score": "0.002242", "ticker_sentiment_label": "Neutral"}, {"ticker": "PROG", "relevance_score": "0.068404", "ticker_sentiment_score": "-0.000152", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monte Rosa Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates", "url": "https://www.globenewswire.com/news-release/2022/03/29/2411785/0/en/Monte-Rosa-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results-and-Business-Updates.html", "time_published": "20220329T113000", "authors": ["Inc.", "Monte Rosa Therapeutics"], "summary": "- Company on Track for Mid-year Filing of Investigational New Drug  ( IND )  Application for Lead Candidate MRT-2359 -", "banner_image": "https://ml.globenewswire.com/Resource/Download/20ed9999-454a-4e2a-aabc-217270a87d2d?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.025097, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLUE", "relevance_score": "0.106431", "ticker_sentiment_score": "0.017554", "ticker_sentiment_label": "Neutral"}]}]}